Info-Tech ITS

SGD 0.735 -1.36% -0.01 Updated 17 Nov 2026, 15:46 SGT

Financials

Annual Report 2025

Open annual report

Auditor’s opinion: a true and fair view. Read auditor’s report (PDF p. 44)

Explore the statements

15 tables

Group statement of financial position

26 metrics

Units appear below each metric. Scroll to compare years

Group statement of financial position from Annual Report 2025
Metric / unit 2025Group / as at 2025-12-312024Group / as at 2024-12-31 Source
Non-current assets
Property, plant and equipmentSingapore dollars thousands 5,0404,262 PDF p. 47
Intangible assetsSingapore dollars thousands 240213 PDF p. 47
Investment in subsidiariesSingapore dollars thousands −− PDF p. 47
Deferred tax assetsSingapore dollars thousands 2,0501,598 PDF p. 47
Total non-current assets (unlabelled in source)Singapore dollars thousands 7,3306,073 PDF p. 47
Current assets
InventoriesSingapore dollars thousands 9884 PDF p. 47
Trade and other receivablesSingapore dollars thousands 9,2203,796 PDF p. 47
Cash and cash equivalentsSingapore dollars thousands 67,28429,715 PDF p. 47
Total current assets (unlabelled in source)Singapore dollars thousands 76,60233,595 PDF p. 47
Total assetsSingapore dollars thousands 83,93239,668 PDF p. 47
Equity
Share capitalSingapore dollars thousands 27,360100 PDF p. 47
Retained earningsSingapore dollars thousands 12,5183,997 PDF p. 47
Translation reserveSingapore dollars thousands 8(115) PDF p. 47
Equity attributable to the owners of the CompanySingapore dollars thousands 39,8863,982 PDF p. 47
Non-current liabilities
Contract liabilitiesSingapore dollars thousands 2,4552,107 PDF p. 47
Lease liabilitiesSingapore dollars thousands 2,8082,422 PDF p. 47
Provision for reinstatement costsSingapore dollars thousands 184127 PDF p. 47
Deferred tax liabilitiesSingapore dollars thousands 12117 PDF p. 47
Total non-current liabilities (unlabelled in source)Singapore dollars thousands 5,5684,673 PDF p. 47
Current liabilities
Trade and other payablesSingapore dollars thousands 7,4434,083 PDF p. 47
Contract liabilitiesSingapore dollars thousands 26,51223,458 PDF p. 47
Lease liabilitiesSingapore dollars thousands 1,1851,120 PDF p. 47
Current tax liabilitiesSingapore dollars thousands 3,3382,352 PDF p. 47
Total current liabilities (unlabelled in source)Singapore dollars thousands 38,47831,013 PDF p. 47
Total liabilitiesSingapore dollars thousands 44,04635,686 PDF p. 47
Total equity and liabilitiesSingapore dollars thousands 83,93239,668 PDF p. 47
Definitions & sources

Four available complete audited Group annual periods are FY2022–FY2025, each 1 January to 31 December. The FY2025 annual report is the first published annual report following the 4 July 2025 SGX listing. FY2022–FY2024 actual consolidated statements are in Appendix A of the official SGX final prospectus dated 27 June 2025. Appendix B unaudited pro forma FY2024 is not substituted for those actual statements. A full FY2021 audited annual statement source has not been established; the opening equity balance at 1 January 2022 is not a complete FY2021 statement set.

All monetary statement amounts are Singapore dollars thousands; basic and diluted earnings per share are Singapore cents. The latest annual report discloses financial position for Group and Company, and Group consolidated combined profit or loss and other comprehensive income, changes in equity and cash flows. Separate Company income, OCI, equity and cash-flow primary statements are not disclosed in the inspected annual report. The historical Appendix A statements are Group consolidated.

The FY2025 audit opinion is unmodified, KPMG LLP, partner Sarina Lee, dated 27 March 2026. Revenue recognition is a key audit matter; the annual auditor report discusses subscription revenue of 39,102 thousand, 69% of revenue. The historical FY2022–FY2024 Appendix A audit opinion is unmodified, KPMG LLP, Sarina Lee, dated 20 June 2025 except for Note 21 subsequent event, for which the date is 27 June 2025. Its report restricts use to inclusion in the listing prospectus.

The current annual report and historical IPO actual statements agree on FY2024 monetary values; original captions, nil rows and cash-flow row order can differ. The original IPO FY2024 income and EPS statement is retained because its EPS denominator differs from the annual comparative.

The FY2025 annual report Note 20 explicitly computes both FY2025 and FY2024 comparative basic EPS using 258,000 thousand shares, assuming that the share split and issuance of new shares had been effected for comparative purposes. EPS is 5.82 cents and 4.78 cents from profits of 15,020 and 12,339 thousand. This is the stated assumed share-capital basis; it is not labelled as an actual time-weighted share count.

The IPO Appendix A Note 19 uses the pre-invitation share capital of 225,000 thousand shares for FY2024, FY2023 and FY2022. Original EPS is respectively 5.48, 4.66 and 3.19 cents on profits of 12,339, 10,487 and 7,185 thousand. Basic and diluted EPS are equal because there are no potential dilutive ordinary shares. The annual-report financial highlights separately disclose FY2022–FY2025 EPS of 2.78, 4.06, 4.78 and 5.82 cents based on 258,000,000 shares. That reported summary is retained separately from the original audited IPO EPS basis.

On 30 May 2025 each of the original 100,000 shares was subdivided into 2,250 shares, producing 225,000,000 shares without changing the S$100,000 share capital. On 4 July 2025 the Company issued 33,000,000 new shares at S$0.87, raising 28,710 thousand gross. Equity issuance expenses were 1,450 thousand; the separately expensed listing costs were 2,930 thousand. Closing ordinary shares were 258,000,000 and share capital 27,360 thousand.

FY2025 Group dividends of 6,499 thousand include a noncash offset of 1,188 thousand against shareholder loans; cash dividends were 5,311 thousand. FY2024 declared dividends of 12,500 less loan offset 10,837 plus the prior-year dividend payable 350 reconcile to cash dividends 2,013. The 774 thousand cash receipt from shareholder loan repayments is separately an investing cash flow.

FY2025 PPE acquisition of 3,140 thousand includes noncash right-of-use assets of 2,178; cash PPE purchase is 962. FY2024 acquisition of 2,324 includes right-of-use assets of 1,943; cash PPE purchase is 381. Right-of-use assets are within PPE and are not an extra asset to add to the balance sheet.

The lease liability reconciliation separates principal payments, interest paid, exchange movements, new leases, derecognition and interest expense. For FY2025, opening 3,542 less total cash outflow 1,477 less FX 114 plus other changes 2,042 equals closing 3,993, which is 2,808 noncurrent plus 1,185 current. FY2024 closing lease liabilities are 3,542, FY2023 2,750 and FY2022 2,844.

New right-of-use assets include reinstatement costs: FY2025 55 thousand and FY2024 7 thousand. Thus FY2025 ROU additions 2,178 differ from new lease liabilities 2,123, and FY2024 ROU additions 1,943 differ from new lease liabilities 1,936. Historical FY2022 ROU additions 2,706 include reinstatement costs 111 versus new lease liabilities 2,595.

Equity rows showing total comprehensive income and total owner transactions are subtotals, rather than additional movements to sum again. Currency translation reclassification on liquidation in FY2024 is retained alongside currency translation differences. No non-controlling interest is invented for wholly owned subsidiaries.

IPO Appendix A Note 21 says the April 2025 dividend of 2,500 thousand was fully settled through a loan offset of 1,188 and cash repayment 774; those two printed amounts sum to 1,962. The annual report separately shows the 774 shareholder loan repayment as an investing cash receipt and reconciles full-year dividends using 6,499 less 1,188 equals 5,311 cash. No missing payment or balancing item is invented. The IPO subsequent-event split wording refers to subdivision into 225,000,000 shares; the annual Note 10 explicitly gives the actual 1:2,250 split from 100,000 to 225,000,000 shares.

Printed dashes are retained as printed. Unlabelled original subtotals are explicitly marked as unlabelled in source. Source links identify the original document and physical page for each row.

FY2023 reported EBITDA in the annual financial highlights is 15,137 thousand, while original operating profit 13,233 plus depreciation 1,612 and amortisation 291 equals 15,136. The printed one-thousand discrepancy is preserved without inventing a rounding or other adjustment.

The complete reported four-year financial highlights include unadjusted EBITDA, three margins, EPS on 258 million shares and dividend per share. FY2025 headline adjusted PAT and adjusted EBITDA on the separate highlights page exclude approximately 2.9 million listing and 0.1 million Malaysia relocation expenses; they are not substituted for statutory profit or the unadjusted EBITDA summary. The summary FY2025 DPS 3.50 cents comprises interim 1.55 cents and final 1.95 cents proposed at the annual-report date; final dividend approval is established by the 24 April 2026 AGM results. Earlier DPS summary dashes are retained despite separate pre-IPO absolute dividend disclosures in the statutory notes.

Company statement of financial position

26 metrics

Units appear below each metric. Scroll to compare years

Company statement of financial position from Annual Report 2025
Metric / unit 2025Company / as at 2025-12-312024Company / as at 2024-12-31 Source
Non-current assets
Property, plant and equipmentSingapore dollars thousands 2,2571,291 PDF p. 47
Intangible assetsSingapore dollars thousands 18453 PDF p. 47
Investment in subsidiariesSingapore dollars thousands 197197 PDF p. 47
Deferred tax assetsSingapore dollars thousands −− PDF p. 47
Total non-current assets (unlabelled in source)Singapore dollars thousands 2,6381,541 PDF p. 47
Current assets
InventoriesSingapore dollars thousands 3531 PDF p. 47
Trade and other receivablesSingapore dollars thousands 15,96110,534 PDF p. 47
Cash and cash equivalentsSingapore dollars thousands 53,53118,989 PDF p. 47
Total current assets (unlabelled in source)Singapore dollars thousands 69,52729,554 PDF p. 47
Total assetsSingapore dollars thousands 72,16531,095 PDF p. 47
Equity
Share capitalSingapore dollars thousands 27,360100 PDF p. 47
Retained earningsSingapore dollars thousands 15,7268,194 PDF p. 47
Translation reserveSingapore dollars thousands −− PDF p. 47
Equity attributable to the owners of the CompanySingapore dollars thousands 43,0868,294 PDF p. 47
Non-current liabilities
Contract liabilitiesSingapore dollars thousands 414391 PDF p. 47
Lease liabilitiesSingapore dollars thousands 829228 PDF p. 47
Provision for reinstatement costsSingapore dollars thousands 184127 PDF p. 47
Deferred tax liabilitiesSingapore dollars thousands 12117 PDF p. 47
Total non-current liabilities (unlabelled in source)Singapore dollars thousands 1,548763 PDF p. 47
Current liabilities
Trade and other payablesSingapore dollars thousands 6,0102,660 PDF p. 47
Contract liabilitiesSingapore dollars thousands 17,63016,328 PDF p. 47
Lease liabilitiesSingapore dollars thousands 570686 PDF p. 47
Current tax liabilitiesSingapore dollars thousands 3,3212,364 PDF p. 47
Total current liabilities (unlabelled in source)Singapore dollars thousands 27,53122,038 PDF p. 47
Total liabilitiesSingapore dollars thousands 29,07922,801 PDF p. 47
Total equity and liabilitiesSingapore dollars thousands 72,16531,095 PDF p. 47
Definitions & sources

Four available complete audited Group annual periods are FY2022–FY2025, each 1 January to 31 December. The FY2025 annual report is the first published annual report following the 4 July 2025 SGX listing. FY2022–FY2024 actual consolidated statements are in Appendix A of the official SGX final prospectus dated 27 June 2025. Appendix B unaudited pro forma FY2024 is not substituted for those actual statements. A full FY2021 audited annual statement source has not been established; the opening equity balance at 1 January 2022 is not a complete FY2021 statement set.

All monetary statement amounts are Singapore dollars thousands; basic and diluted earnings per share are Singapore cents. The latest annual report discloses financial position for Group and Company, and Group consolidated combined profit or loss and other comprehensive income, changes in equity and cash flows. Separate Company income, OCI, equity and cash-flow primary statements are not disclosed in the inspected annual report. The historical Appendix A statements are Group consolidated.

The FY2025 audit opinion is unmodified, KPMG LLP, partner Sarina Lee, dated 27 March 2026. Revenue recognition is a key audit matter; the annual auditor report discusses subscription revenue of 39,102 thousand, 69% of revenue. The historical FY2022–FY2024 Appendix A audit opinion is unmodified, KPMG LLP, Sarina Lee, dated 20 June 2025 except for Note 21 subsequent event, for which the date is 27 June 2025. Its report restricts use to inclusion in the listing prospectus.

The current annual report and historical IPO actual statements agree on FY2024 monetary values; original captions, nil rows and cash-flow row order can differ. The original IPO FY2024 income and EPS statement is retained because its EPS denominator differs from the annual comparative.

The FY2025 annual report Note 20 explicitly computes both FY2025 and FY2024 comparative basic EPS using 258,000 thousand shares, assuming that the share split and issuance of new shares had been effected for comparative purposes. EPS is 5.82 cents and 4.78 cents from profits of 15,020 and 12,339 thousand. This is the stated assumed share-capital basis; it is not labelled as an actual time-weighted share count.

The IPO Appendix A Note 19 uses the pre-invitation share capital of 225,000 thousand shares for FY2024, FY2023 and FY2022. Original EPS is respectively 5.48, 4.66 and 3.19 cents on profits of 12,339, 10,487 and 7,185 thousand. Basic and diluted EPS are equal because there are no potential dilutive ordinary shares. The annual-report financial highlights separately disclose FY2022–FY2025 EPS of 2.78, 4.06, 4.78 and 5.82 cents based on 258,000,000 shares. That reported summary is retained separately from the original audited IPO EPS basis.

On 30 May 2025 each of the original 100,000 shares was subdivided into 2,250 shares, producing 225,000,000 shares without changing the S$100,000 share capital. On 4 July 2025 the Company issued 33,000,000 new shares at S$0.87, raising 28,710 thousand gross. Equity issuance expenses were 1,450 thousand; the separately expensed listing costs were 2,930 thousand. Closing ordinary shares were 258,000,000 and share capital 27,360 thousand.

FY2025 Group dividends of 6,499 thousand include a noncash offset of 1,188 thousand against shareholder loans; cash dividends were 5,311 thousand. FY2024 declared dividends of 12,500 less loan offset 10,837 plus the prior-year dividend payable 350 reconcile to cash dividends 2,013. The 774 thousand cash receipt from shareholder loan repayments is separately an investing cash flow.

FY2025 PPE acquisition of 3,140 thousand includes noncash right-of-use assets of 2,178; cash PPE purchase is 962. FY2024 acquisition of 2,324 includes right-of-use assets of 1,943; cash PPE purchase is 381. Right-of-use assets are within PPE and are not an extra asset to add to the balance sheet.

The lease liability reconciliation separates principal payments, interest paid, exchange movements, new leases, derecognition and interest expense. For FY2025, opening 3,542 less total cash outflow 1,477 less FX 114 plus other changes 2,042 equals closing 3,993, which is 2,808 noncurrent plus 1,185 current. FY2024 closing lease liabilities are 3,542, FY2023 2,750 and FY2022 2,844.

New right-of-use assets include reinstatement costs: FY2025 55 thousand and FY2024 7 thousand. Thus FY2025 ROU additions 2,178 differ from new lease liabilities 2,123, and FY2024 ROU additions 1,943 differ from new lease liabilities 1,936. Historical FY2022 ROU additions 2,706 include reinstatement costs 111 versus new lease liabilities 2,595.

Equity rows showing total comprehensive income and total owner transactions are subtotals, rather than additional movements to sum again. Currency translation reclassification on liquidation in FY2024 is retained alongside currency translation differences. No non-controlling interest is invented for wholly owned subsidiaries.

IPO Appendix A Note 21 says the April 2025 dividend of 2,500 thousand was fully settled through a loan offset of 1,188 and cash repayment 774; those two printed amounts sum to 1,962. The annual report separately shows the 774 shareholder loan repayment as an investing cash receipt and reconciles full-year dividends using 6,499 less 1,188 equals 5,311 cash. No missing payment or balancing item is invented. The IPO subsequent-event split wording refers to subdivision into 225,000,000 shares; the annual Note 10 explicitly gives the actual 1:2,250 split from 100,000 to 225,000,000 shares.

Printed dashes are retained as printed. Unlabelled original subtotals are explicitly marked as unlabelled in source. Source links identify the original document and physical page for each row.

FY2023 reported EBITDA in the annual financial highlights is 15,137 thousand, while original operating profit 13,233 plus depreciation 1,612 and amortisation 291 equals 15,136. The printed one-thousand discrepancy is preserved without inventing a rounding or other adjustment.

The complete reported four-year financial highlights include unadjusted EBITDA, three margins, EPS on 258 million shares and dividend per share. FY2025 headline adjusted PAT and adjusted EBITDA on the separate highlights page exclude approximately 2.9 million listing and 0.1 million Malaysia relocation expenses; they are not substituted for statutory profit or the unadjusted EBITDA summary. The summary FY2025 DPS 3.50 cents comprises interim 1.55 cents and final 1.95 cents proposed at the annual-report date; final dividend approval is established by the 24 April 2026 AGM results. Earlier DPS summary dashes are retained despite separate pre-IPO absolute dividend disclosures in the statutory notes.

Group combined profit or loss and other comprehensive income

20 metrics

Units appear below each metric. Scroll to compare years

Group combined profit or loss and other comprehensive income from Annual Report 2025
Metric / unit 2025Group / 12-month period 2025-01-01 to 2025-12-312024Group / 12-month period 2024-01-01 to 2024-12-31 Source
income
RevenueSingapore dollars thousands 56,48643,713 PDF p. 48
Cost of salesSingapore dollars thousands (8,363)(6,297) PDF p. 48
Gross profitSingapore dollars thousands 48,12337,416 PDF p. 48
Other incomeSingapore dollars thousands 200115 PDF p. 48
Selling and distribution expensesSingapore dollars thousands (10,004)(9,492) PDF p. 48
Administrative expensesSingapore dollars thousands (11,394)(8,920) PDF p. 48
Research and development expensesSingapore dollars thousands (4,187)(3,693) PDF p. 48
Other expensesSingapore dollars thousands (3,800)(515) PDF p. 48
Operating profitSingapore dollars thousands 18,93814,911 PDF p. 48
Finance incomeSingapore dollars thousands 476325 PDF p. 48
Finance costsSingapore dollars thousands (352)(338) PDF p. 48
Net finance income/(costs)Singapore dollars thousands 124(13) PDF p. 48
Profit before taxSingapore dollars thousands 19,06214,898 PDF p. 48
Tax expenseSingapore dollars thousands (4,042)(2,559) PDF p. 48
Profit for the yearSingapore dollars thousands 15,02012,339 PDF p. 48
Foreign operations:
– Currency translation differencesSingapore dollars thousands 123(147) PDF p. 48
– Currency translation differences reclassified to profit or loss on liquidation of subsidiariesSingapore dollars thousands −(65) PDF p. 48
Total comprehensive income
Total comprehensive income for the year attributable to the Owners of the CompanySingapore dollars thousands 15,14312,127 PDF p. 48
Earnings per share attributable to the ordinary equity holders of the Company during the financial year
Basic earnings per share (cents)Singapore cents per share 5.824.78 PDF p. 48
Diluted earnings per share (cents)Singapore cents per share 5.824.78 PDF p. 48
Definitions & sources

Four available complete audited Group annual periods are FY2022–FY2025, each 1 January to 31 December. The FY2025 annual report is the first published annual report following the 4 July 2025 SGX listing. FY2022–FY2024 actual consolidated statements are in Appendix A of the official SGX final prospectus dated 27 June 2025. Appendix B unaudited pro forma FY2024 is not substituted for those actual statements. A full FY2021 audited annual statement source has not been established; the opening equity balance at 1 January 2022 is not a complete FY2021 statement set.

All monetary statement amounts are Singapore dollars thousands; basic and diluted earnings per share are Singapore cents. The latest annual report discloses financial position for Group and Company, and Group consolidated combined profit or loss and other comprehensive income, changes in equity and cash flows. Separate Company income, OCI, equity and cash-flow primary statements are not disclosed in the inspected annual report. The historical Appendix A statements are Group consolidated.

The FY2025 audit opinion is unmodified, KPMG LLP, partner Sarina Lee, dated 27 March 2026. Revenue recognition is a key audit matter; the annual auditor report discusses subscription revenue of 39,102 thousand, 69% of revenue. The historical FY2022–FY2024 Appendix A audit opinion is unmodified, KPMG LLP, Sarina Lee, dated 20 June 2025 except for Note 21 subsequent event, for which the date is 27 June 2025. Its report restricts use to inclusion in the listing prospectus.

The current annual report and historical IPO actual statements agree on FY2024 monetary values; original captions, nil rows and cash-flow row order can differ. The original IPO FY2024 income and EPS statement is retained because its EPS denominator differs from the annual comparative.

The FY2025 annual report Note 20 explicitly computes both FY2025 and FY2024 comparative basic EPS using 258,000 thousand shares, assuming that the share split and issuance of new shares had been effected for comparative purposes. EPS is 5.82 cents and 4.78 cents from profits of 15,020 and 12,339 thousand. This is the stated assumed share-capital basis; it is not labelled as an actual time-weighted share count.

The IPO Appendix A Note 19 uses the pre-invitation share capital of 225,000 thousand shares for FY2024, FY2023 and FY2022. Original EPS is respectively 5.48, 4.66 and 3.19 cents on profits of 12,339, 10,487 and 7,185 thousand. Basic and diluted EPS are equal because there are no potential dilutive ordinary shares. The annual-report financial highlights separately disclose FY2022–FY2025 EPS of 2.78, 4.06, 4.78 and 5.82 cents based on 258,000,000 shares. That reported summary is retained separately from the original audited IPO EPS basis.

On 30 May 2025 each of the original 100,000 shares was subdivided into 2,250 shares, producing 225,000,000 shares without changing the S$100,000 share capital. On 4 July 2025 the Company issued 33,000,000 new shares at S$0.87, raising 28,710 thousand gross. Equity issuance expenses were 1,450 thousand; the separately expensed listing costs were 2,930 thousand. Closing ordinary shares were 258,000,000 and share capital 27,360 thousand.

FY2025 Group dividends of 6,499 thousand include a noncash offset of 1,188 thousand against shareholder loans; cash dividends were 5,311 thousand. FY2024 declared dividends of 12,500 less loan offset 10,837 plus the prior-year dividend payable 350 reconcile to cash dividends 2,013. The 774 thousand cash receipt from shareholder loan repayments is separately an investing cash flow.

FY2025 PPE acquisition of 3,140 thousand includes noncash right-of-use assets of 2,178; cash PPE purchase is 962. FY2024 acquisition of 2,324 includes right-of-use assets of 1,943; cash PPE purchase is 381. Right-of-use assets are within PPE and are not an extra asset to add to the balance sheet.

The lease liability reconciliation separates principal payments, interest paid, exchange movements, new leases, derecognition and interest expense. For FY2025, opening 3,542 less total cash outflow 1,477 less FX 114 plus other changes 2,042 equals closing 3,993, which is 2,808 noncurrent plus 1,185 current. FY2024 closing lease liabilities are 3,542, FY2023 2,750 and FY2022 2,844.

New right-of-use assets include reinstatement costs: FY2025 55 thousand and FY2024 7 thousand. Thus FY2025 ROU additions 2,178 differ from new lease liabilities 2,123, and FY2024 ROU additions 1,943 differ from new lease liabilities 1,936. Historical FY2022 ROU additions 2,706 include reinstatement costs 111 versus new lease liabilities 2,595.

Equity rows showing total comprehensive income and total owner transactions are subtotals, rather than additional movements to sum again. Currency translation reclassification on liquidation in FY2024 is retained alongside currency translation differences. No non-controlling interest is invented for wholly owned subsidiaries.

IPO Appendix A Note 21 says the April 2025 dividend of 2,500 thousand was fully settled through a loan offset of 1,188 and cash repayment 774; those two printed amounts sum to 1,962. The annual report separately shows the 774 shareholder loan repayment as an investing cash receipt and reconciles full-year dividends using 6,499 less 1,188 equals 5,311 cash. No missing payment or balancing item is invented. The IPO subsequent-event split wording refers to subdivision into 225,000,000 shares; the annual Note 10 explicitly gives the actual 1:2,250 split from 100,000 to 225,000,000 shares.

Printed dashes are retained as printed. Unlabelled original subtotals are explicitly marked as unlabelled in source. Source links identify the original document and physical page for each row.

FY2023 reported EBITDA in the annual financial highlights is 15,137 thousand, while original operating profit 13,233 plus depreciation 1,612 and amortisation 291 equals 15,136. The printed one-thousand discrepancy is preserved without inventing a rounding or other adjustment.

The complete reported four-year financial highlights include unadjusted EBITDA, three margins, EPS on 258 million shares and dividend per share. FY2025 headline adjusted PAT and adjusted EBITDA on the separate highlights page exclude approximately 2.9 million listing and 0.1 million Malaysia relocation expenses; they are not substituted for statutory profit or the unadjusted EBITDA summary. The summary FY2025 DPS 3.50 cents comprises interim 1.55 cents and final 1.95 cents proposed at the annual-report date; final dividend approval is established by the 24 April 2026 AGM results. Earlier DPS summary dashes are retained despite separate pre-IPO absolute dividend disclosures in the statutory notes.

Group consolidated cash flows

37 metrics

Units appear below each metric. Scroll to compare years

Group consolidated cash flows from Annual Report 2025
Metric / unit 2025Group / 12-month period 2025-01-01 to 2025-12-312024Group / 12-month period 2024-01-01 to 2024-12-31 Source
Cash flows from operating activities
Profit before taxSingapore dollars thousands 19,06214,898 PDF p. 50
Adjustments for:
Depreciation of property, plant and equipmentSingapore dollars thousands 2,0501,757 PDF p. 50
Amortisation of intangible assetsSingapore dollars thousands 168346 PDF p. 50
Property, plant and equipment written offSingapore dollars thousands 64105 PDF p. 50
Intangible assets written offSingapore dollars thousands −10 PDF p. 50
Gain on derecognition of leaseSingapore dollars thousands (30)(7) PDF p. 50
Gain on liquidation of subsidiariesSingapore dollars thousands −(65) PDF p. 50
(Reversal of impairment loss)/Impairment loss on trade receivablesSingapore dollars thousands (31)111 PDF p. 50
Bad debts written offSingapore dollars thousands 4644 PDF p. 50
Interest incomeSingapore dollars thousands (476)(325) PDF p. 50
Interest on lease liabilitiesSingapore dollars thousands 189194 PDF p. 50
Unwinding of discount on provision for reinstatement costsSingapore dollars thousands 24 PDF p. 50
Operating cash before changes in working capital (unlabelled in source)Singapore dollars thousands 21,04417,072 PDF p. 50
Changes in:
InventoriesSingapore dollars thousands (15)64 PDF p. 50
Trade and other receivablesSingapore dollars thousands (7,407)969 PDF p. 50
Trade and other payablesSingapore dollars thousands 3,311860 PDF p. 50
Contract liabilitiesSingapore dollars thousands 3,2552,410 PDF p. 50
Cash flows from operating activities
Cash generated from operationsSingapore dollars thousands 20,18821,375 PDF p. 50
Tax paidSingapore dollars thousands (3,360)(3,349) PDF p. 50
Net cash generated from operating activitiesSingapore dollars thousands 16,82818,026 PDF p. 50
Cash flows from investing activities
Purchase of property, plant and equipmentSingapore dollars thousands (962)(381) PDF p. 50
Purchase of intangible assetsSingapore dollars thousands (24)(15) PDF p. 50
Capitalisation of development costsSingapore dollars thousands (172)− PDF p. 50
Receipt of interest incomeSingapore dollars thousands 476325 PDF p. 50
Receipt of loan repayment from shareholdersSingapore dollars thousands 774− PDF p. 50
Loan to shareholdersSingapore dollars thousands −(3,000) PDF p. 50
Net cash generated from/(used in) investing activitiesSingapore dollars thousands 92(3,071) PDF p. 50
Cash flows from financing activities
Payment of lease liabilitiesSingapore dollars thousands (1,288)(1,116) PDF p. 50
Dividends paidSingapore dollars thousands (5,311)(2,013) PDF p. 50
Interests paidSingapore dollars thousands (189)(194) PDF p. 50
Proceeds from issue of share capitalSingapore dollars thousands 28,710− PDF p. 50
Payment of share issuance expensesSingapore dollars thousands (1,450)− PDF p. 50
Net cash generated from/(used in) financing activitiesSingapore dollars thousands 20,472(3,323) PDF p. 50
Cash and cash equivalents reconciliation
Net increase in cash and cash equivalentsSingapore dollars thousands 37,39211,632 PDF p. 50
Cash and cash equivalents at 1 JanuarySingapore dollars thousands 29,71517,792 PDF p. 50
Effect of exchange rates fluctuations on cash and cash equivalentsSingapore dollars thousands 177291 PDF p. 50
Cash and cash equivalents at 31 DecemberSingapore dollars thousands 67,28429,715 PDF p. 50
Definitions & sources

Four available complete audited Group annual periods are FY2022–FY2025, each 1 January to 31 December. The FY2025 annual report is the first published annual report following the 4 July 2025 SGX listing. FY2022–FY2024 actual consolidated statements are in Appendix A of the official SGX final prospectus dated 27 June 2025. Appendix B unaudited pro forma FY2024 is not substituted for those actual statements. A full FY2021 audited annual statement source has not been established; the opening equity balance at 1 January 2022 is not a complete FY2021 statement set.

All monetary statement amounts are Singapore dollars thousands; basic and diluted earnings per share are Singapore cents. The latest annual report discloses financial position for Group and Company, and Group consolidated combined profit or loss and other comprehensive income, changes in equity and cash flows. Separate Company income, OCI, equity and cash-flow primary statements are not disclosed in the inspected annual report. The historical Appendix A statements are Group consolidated.

The FY2025 audit opinion is unmodified, KPMG LLP, partner Sarina Lee, dated 27 March 2026. Revenue recognition is a key audit matter; the annual auditor report discusses subscription revenue of 39,102 thousand, 69% of revenue. The historical FY2022–FY2024 Appendix A audit opinion is unmodified, KPMG LLP, Sarina Lee, dated 20 June 2025 except for Note 21 subsequent event, for which the date is 27 June 2025. Its report restricts use to inclusion in the listing prospectus.

The current annual report and historical IPO actual statements agree on FY2024 monetary values; original captions, nil rows and cash-flow row order can differ. The original IPO FY2024 income and EPS statement is retained because its EPS denominator differs from the annual comparative.

The FY2025 annual report Note 20 explicitly computes both FY2025 and FY2024 comparative basic EPS using 258,000 thousand shares, assuming that the share split and issuance of new shares had been effected for comparative purposes. EPS is 5.82 cents and 4.78 cents from profits of 15,020 and 12,339 thousand. This is the stated assumed share-capital basis; it is not labelled as an actual time-weighted share count.

The IPO Appendix A Note 19 uses the pre-invitation share capital of 225,000 thousand shares for FY2024, FY2023 and FY2022. Original EPS is respectively 5.48, 4.66 and 3.19 cents on profits of 12,339, 10,487 and 7,185 thousand. Basic and diluted EPS are equal because there are no potential dilutive ordinary shares. The annual-report financial highlights separately disclose FY2022–FY2025 EPS of 2.78, 4.06, 4.78 and 5.82 cents based on 258,000,000 shares. That reported summary is retained separately from the original audited IPO EPS basis.

On 30 May 2025 each of the original 100,000 shares was subdivided into 2,250 shares, producing 225,000,000 shares without changing the S$100,000 share capital. On 4 July 2025 the Company issued 33,000,000 new shares at S$0.87, raising 28,710 thousand gross. Equity issuance expenses were 1,450 thousand; the separately expensed listing costs were 2,930 thousand. Closing ordinary shares were 258,000,000 and share capital 27,360 thousand.

FY2025 Group dividends of 6,499 thousand include a noncash offset of 1,188 thousand against shareholder loans; cash dividends were 5,311 thousand. FY2024 declared dividends of 12,500 less loan offset 10,837 plus the prior-year dividend payable 350 reconcile to cash dividends 2,013. The 774 thousand cash receipt from shareholder loan repayments is separately an investing cash flow.

FY2025 PPE acquisition of 3,140 thousand includes noncash right-of-use assets of 2,178; cash PPE purchase is 962. FY2024 acquisition of 2,324 includes right-of-use assets of 1,943; cash PPE purchase is 381. Right-of-use assets are within PPE and are not an extra asset to add to the balance sheet.

The lease liability reconciliation separates principal payments, interest paid, exchange movements, new leases, derecognition and interest expense. For FY2025, opening 3,542 less total cash outflow 1,477 less FX 114 plus other changes 2,042 equals closing 3,993, which is 2,808 noncurrent plus 1,185 current. FY2024 closing lease liabilities are 3,542, FY2023 2,750 and FY2022 2,844.

New right-of-use assets include reinstatement costs: FY2025 55 thousand and FY2024 7 thousand. Thus FY2025 ROU additions 2,178 differ from new lease liabilities 2,123, and FY2024 ROU additions 1,943 differ from new lease liabilities 1,936. Historical FY2022 ROU additions 2,706 include reinstatement costs 111 versus new lease liabilities 2,595.

Equity rows showing total comprehensive income and total owner transactions are subtotals, rather than additional movements to sum again. Currency translation reclassification on liquidation in FY2024 is retained alongside currency translation differences. No non-controlling interest is invented for wholly owned subsidiaries.

IPO Appendix A Note 21 says the April 2025 dividend of 2,500 thousand was fully settled through a loan offset of 1,188 and cash repayment 774; those two printed amounts sum to 1,962. The annual report separately shows the 774 shareholder loan repayment as an investing cash receipt and reconciles full-year dividends using 6,499 less 1,188 equals 5,311 cash. No missing payment or balancing item is invented. The IPO subsequent-event split wording refers to subdivision into 225,000,000 shares; the annual Note 10 explicitly gives the actual 1:2,250 split from 100,000 to 225,000,000 shares.

Printed dashes are retained as printed. Unlabelled original subtotals are explicitly marked as unlabelled in source. Source links identify the original document and physical page for each row.

FY2023 reported EBITDA in the annual financial highlights is 15,137 thousand, while original operating profit 13,233 plus depreciation 1,612 and amortisation 291 equals 15,136. The printed one-thousand discrepancy is preserved without inventing a rounding or other adjustment.

The complete reported four-year financial highlights include unadjusted EBITDA, three margins, EPS on 258 million shares and dividend per share. FY2025 headline adjusted PAT and adjusted EBITDA on the separate highlights page exclude approximately 2.9 million listing and 0.1 million Malaysia relocation expenses; they are not substituted for statutory profit or the unadjusted EBITDA summary. The summary FY2025 DPS 3.50 cents comprises interim 1.55 cents and final 1.95 cents proposed at the annual-report date; final dividend approval is established by the 24 April 2026 AGM results. Earlier DPS summary dashes are retained despite separate pre-IPO absolute dividend disclosures in the statutory notes.

Group lease liability financing reconciliation

10 metrics

Units appear below each metric. Scroll to compare years

Group lease liability financing reconciliation from Annual Report 2025
Metric / unit 2025Group / 12-month period 2025-01-01 to 2025-12-312024Group / 12-month period 2024-01-01 to 2024-12-31 Source
Group
At 1 JanuarySingapore dollars thousands 3,5422,750 PDF p. 73
Changes in financing cash flows
Payment of lease liabilitiesSingapore dollars thousands (1,288)(1,116) PDF p. 73
Group
Interest paidSingapore dollars thousands (189)(194) PDF p. 73
Total changes from financing cash flowsSingapore dollars thousands (1,477)(1,310) PDF p. 73
Effect of changes in foreign exchange ratesSingapore dollars thousands (114)51 PDF p. 73
Liability-related other changes
New leasesSingapore dollars thousands 2,1231,936 PDF p. 73
Derecognition of lease liabilitiesSingapore dollars thousands (270)(79) PDF p. 73
Group
Interest expenseSingapore dollars thousands 189194 PDF p. 73
Total liability-related other changesSingapore dollars thousands 2,0422,051 PDF p. 73
Balance at 31 DecemberSingapore dollars thousands 3,9933,542 PDF p. 73
Definitions & sources

Four available complete audited Group annual periods are FY2022–FY2025, each 1 January to 31 December. The FY2025 annual report is the first published annual report following the 4 July 2025 SGX listing. FY2022–FY2024 actual consolidated statements are in Appendix A of the official SGX final prospectus dated 27 June 2025. Appendix B unaudited pro forma FY2024 is not substituted for those actual statements. A full FY2021 audited annual statement source has not been established; the opening equity balance at 1 January 2022 is not a complete FY2021 statement set.

All monetary statement amounts are Singapore dollars thousands; basic and diluted earnings per share are Singapore cents. The latest annual report discloses financial position for Group and Company, and Group consolidated combined profit or loss and other comprehensive income, changes in equity and cash flows. Separate Company income, OCI, equity and cash-flow primary statements are not disclosed in the inspected annual report. The historical Appendix A statements are Group consolidated.

The FY2025 audit opinion is unmodified, KPMG LLP, partner Sarina Lee, dated 27 March 2026. Revenue recognition is a key audit matter; the annual auditor report discusses subscription revenue of 39,102 thousand, 69% of revenue. The historical FY2022–FY2024 Appendix A audit opinion is unmodified, KPMG LLP, Sarina Lee, dated 20 June 2025 except for Note 21 subsequent event, for which the date is 27 June 2025. Its report restricts use to inclusion in the listing prospectus.

The current annual report and historical IPO actual statements agree on FY2024 monetary values; original captions, nil rows and cash-flow row order can differ. The original IPO FY2024 income and EPS statement is retained because its EPS denominator differs from the annual comparative.

The FY2025 annual report Note 20 explicitly computes both FY2025 and FY2024 comparative basic EPS using 258,000 thousand shares, assuming that the share split and issuance of new shares had been effected for comparative purposes. EPS is 5.82 cents and 4.78 cents from profits of 15,020 and 12,339 thousand. This is the stated assumed share-capital basis; it is not labelled as an actual time-weighted share count.

The IPO Appendix A Note 19 uses the pre-invitation share capital of 225,000 thousand shares for FY2024, FY2023 and FY2022. Original EPS is respectively 5.48, 4.66 and 3.19 cents on profits of 12,339, 10,487 and 7,185 thousand. Basic and diluted EPS are equal because there are no potential dilutive ordinary shares. The annual-report financial highlights separately disclose FY2022–FY2025 EPS of 2.78, 4.06, 4.78 and 5.82 cents based on 258,000,000 shares. That reported summary is retained separately from the original audited IPO EPS basis.

On 30 May 2025 each of the original 100,000 shares was subdivided into 2,250 shares, producing 225,000,000 shares without changing the S$100,000 share capital. On 4 July 2025 the Company issued 33,000,000 new shares at S$0.87, raising 28,710 thousand gross. Equity issuance expenses were 1,450 thousand; the separately expensed listing costs were 2,930 thousand. Closing ordinary shares were 258,000,000 and share capital 27,360 thousand.

FY2025 Group dividends of 6,499 thousand include a noncash offset of 1,188 thousand against shareholder loans; cash dividends were 5,311 thousand. FY2024 declared dividends of 12,500 less loan offset 10,837 plus the prior-year dividend payable 350 reconcile to cash dividends 2,013. The 774 thousand cash receipt from shareholder loan repayments is separately an investing cash flow.

FY2025 PPE acquisition of 3,140 thousand includes noncash right-of-use assets of 2,178; cash PPE purchase is 962. FY2024 acquisition of 2,324 includes right-of-use assets of 1,943; cash PPE purchase is 381. Right-of-use assets are within PPE and are not an extra asset to add to the balance sheet.

The lease liability reconciliation separates principal payments, interest paid, exchange movements, new leases, derecognition and interest expense. For FY2025, opening 3,542 less total cash outflow 1,477 less FX 114 plus other changes 2,042 equals closing 3,993, which is 2,808 noncurrent plus 1,185 current. FY2024 closing lease liabilities are 3,542, FY2023 2,750 and FY2022 2,844.

New right-of-use assets include reinstatement costs: FY2025 55 thousand and FY2024 7 thousand. Thus FY2025 ROU additions 2,178 differ from new lease liabilities 2,123, and FY2024 ROU additions 1,943 differ from new lease liabilities 1,936. Historical FY2022 ROU additions 2,706 include reinstatement costs 111 versus new lease liabilities 2,595.

Equity rows showing total comprehensive income and total owner transactions are subtotals, rather than additional movements to sum again. Currency translation reclassification on liquidation in FY2024 is retained alongside currency translation differences. No non-controlling interest is invented for wholly owned subsidiaries.

IPO Appendix A Note 21 says the April 2025 dividend of 2,500 thousand was fully settled through a loan offset of 1,188 and cash repayment 774; those two printed amounts sum to 1,962. The annual report separately shows the 774 shareholder loan repayment as an investing cash receipt and reconciles full-year dividends using 6,499 less 1,188 equals 5,311 cash. No missing payment or balancing item is invented. The IPO subsequent-event split wording refers to subdivision into 225,000,000 shares; the annual Note 10 explicitly gives the actual 1:2,250 split from 100,000 to 225,000,000 shares.

Printed dashes are retained as printed. Unlabelled original subtotals are explicitly marked as unlabelled in source. Source links identify the original document and physical page for each row.

FY2023 reported EBITDA in the annual financial highlights is 15,137 thousand, while original operating profit 13,233 plus depreciation 1,612 and amortisation 291 equals 15,136. The printed one-thousand discrepancy is preserved without inventing a rounding or other adjustment.

The complete reported four-year financial highlights include unadjusted EBITDA, three margins, EPS on 258 million shares and dividend per share. FY2025 headline adjusted PAT and adjusted EBITDA on the separate highlights page exclude approximately 2.9 million listing and 0.1 million Malaysia relocation expenses; they are not substituted for statutory profit or the unadjusted EBITDA summary. The summary FY2025 DPS 3.50 cents comprises interim 1.55 cents and final 1.95 cents proposed at the annual-report date; final dividend approval is established by the 24 April 2026 AGM results. Earlier DPS summary dashes are retained despite separate pre-IPO absolute dividend disclosures in the statutory notes.

Group changes in equity / 2025

9 metrics

Units appear below each metric. Scroll to compare years

Group changes in equity / 2025 from Annual Report 2025
Metric / unit 2025Group / Share capital / 12-month period 2025-01-01 to 2025-12-312025Group / Retained earnings / 12-month period 2025-01-01 to 2025-12-312025Group / Translation reserve / 12-month period 2025-01-01 to 2025-12-312025Group / Total equity / 12-month period 2025-01-01 to 2025-12-31 Source
Changes in equity / Group / 2025
At 1 January 2025Singapore dollars thousands 1003,997(115)3,982 PDF p. 49
Profit for the yearSingapore dollars thousands −15,020−15,020 PDF p. 49
– Currency translation differencesSingapore dollars thousands −−123123 PDF p. 49
Total comprehensive income for the yearSingapore dollars thousands –15,02012315,143 PDF p. 49
– Issuance of IPO shareSingapore dollars thousands 28,710−−28,710 PDF p. 49
– Share issuance expenseSingapore dollars thousands (1,450)−−(1,450) PDF p. 49
– Dividends paidSingapore dollars thousands −(6,499)−(6,499) PDF p. 49
Total transactions with ownersSingapore dollars thousands 27,260(6,499)−20,761 PDF p. 49
At 31 December 2025Singapore dollars thousands 27,36012,518839,886 PDF p. 49
Definitions & sources

Four available complete audited Group annual periods are FY2022–FY2025, each 1 January to 31 December. The FY2025 annual report is the first published annual report following the 4 July 2025 SGX listing. FY2022–FY2024 actual consolidated statements are in Appendix A of the official SGX final prospectus dated 27 June 2025. Appendix B unaudited pro forma FY2024 is not substituted for those actual statements. A full FY2021 audited annual statement source has not been established; the opening equity balance at 1 January 2022 is not a complete FY2021 statement set.

All monetary statement amounts are Singapore dollars thousands; basic and diluted earnings per share are Singapore cents. The latest annual report discloses financial position for Group and Company, and Group consolidated combined profit or loss and other comprehensive income, changes in equity and cash flows. Separate Company income, OCI, equity and cash-flow primary statements are not disclosed in the inspected annual report. The historical Appendix A statements are Group consolidated.

The FY2025 audit opinion is unmodified, KPMG LLP, partner Sarina Lee, dated 27 March 2026. Revenue recognition is a key audit matter; the annual auditor report discusses subscription revenue of 39,102 thousand, 69% of revenue. The historical FY2022–FY2024 Appendix A audit opinion is unmodified, KPMG LLP, Sarina Lee, dated 20 June 2025 except for Note 21 subsequent event, for which the date is 27 June 2025. Its report restricts use to inclusion in the listing prospectus.

The current annual report and historical IPO actual statements agree on FY2024 monetary values; original captions, nil rows and cash-flow row order can differ. The original IPO FY2024 income and EPS statement is retained because its EPS denominator differs from the annual comparative.

The FY2025 annual report Note 20 explicitly computes both FY2025 and FY2024 comparative basic EPS using 258,000 thousand shares, assuming that the share split and issuance of new shares had been effected for comparative purposes. EPS is 5.82 cents and 4.78 cents from profits of 15,020 and 12,339 thousand. This is the stated assumed share-capital basis; it is not labelled as an actual time-weighted share count.

The IPO Appendix A Note 19 uses the pre-invitation share capital of 225,000 thousand shares for FY2024, FY2023 and FY2022. Original EPS is respectively 5.48, 4.66 and 3.19 cents on profits of 12,339, 10,487 and 7,185 thousand. Basic and diluted EPS are equal because there are no potential dilutive ordinary shares. The annual-report financial highlights separately disclose FY2022–FY2025 EPS of 2.78, 4.06, 4.78 and 5.82 cents based on 258,000,000 shares. That reported summary is retained separately from the original audited IPO EPS basis.

On 30 May 2025 each of the original 100,000 shares was subdivided into 2,250 shares, producing 225,000,000 shares without changing the S$100,000 share capital. On 4 July 2025 the Company issued 33,000,000 new shares at S$0.87, raising 28,710 thousand gross. Equity issuance expenses were 1,450 thousand; the separately expensed listing costs were 2,930 thousand. Closing ordinary shares were 258,000,000 and share capital 27,360 thousand.

FY2025 Group dividends of 6,499 thousand include a noncash offset of 1,188 thousand against shareholder loans; cash dividends were 5,311 thousand. FY2024 declared dividends of 12,500 less loan offset 10,837 plus the prior-year dividend payable 350 reconcile to cash dividends 2,013. The 774 thousand cash receipt from shareholder loan repayments is separately an investing cash flow.

FY2025 PPE acquisition of 3,140 thousand includes noncash right-of-use assets of 2,178; cash PPE purchase is 962. FY2024 acquisition of 2,324 includes right-of-use assets of 1,943; cash PPE purchase is 381. Right-of-use assets are within PPE and are not an extra asset to add to the balance sheet.

The lease liability reconciliation separates principal payments, interest paid, exchange movements, new leases, derecognition and interest expense. For FY2025, opening 3,542 less total cash outflow 1,477 less FX 114 plus other changes 2,042 equals closing 3,993, which is 2,808 noncurrent plus 1,185 current. FY2024 closing lease liabilities are 3,542, FY2023 2,750 and FY2022 2,844.

New right-of-use assets include reinstatement costs: FY2025 55 thousand and FY2024 7 thousand. Thus FY2025 ROU additions 2,178 differ from new lease liabilities 2,123, and FY2024 ROU additions 1,943 differ from new lease liabilities 1,936. Historical FY2022 ROU additions 2,706 include reinstatement costs 111 versus new lease liabilities 2,595.

Equity rows showing total comprehensive income and total owner transactions are subtotals, rather than additional movements to sum again. Currency translation reclassification on liquidation in FY2024 is retained alongside currency translation differences. No non-controlling interest is invented for wholly owned subsidiaries.

IPO Appendix A Note 21 says the April 2025 dividend of 2,500 thousand was fully settled through a loan offset of 1,188 and cash repayment 774; those two printed amounts sum to 1,962. The annual report separately shows the 774 shareholder loan repayment as an investing cash receipt and reconciles full-year dividends using 6,499 less 1,188 equals 5,311 cash. No missing payment or balancing item is invented. The IPO subsequent-event split wording refers to subdivision into 225,000,000 shares; the annual Note 10 explicitly gives the actual 1:2,250 split from 100,000 to 225,000,000 shares.

Printed dashes are retained as printed. Unlabelled original subtotals are explicitly marked as unlabelled in source. Source links identify the original document and physical page for each row.

FY2023 reported EBITDA in the annual financial highlights is 15,137 thousand, while original operating profit 13,233 plus depreciation 1,612 and amortisation 291 equals 15,136. The printed one-thousand discrepancy is preserved without inventing a rounding or other adjustment.

The complete reported four-year financial highlights include unadjusted EBITDA, three margins, EPS on 258 million shares and dividend per share. FY2025 headline adjusted PAT and adjusted EBITDA on the separate highlights page exclude approximately 2.9 million listing and 0.1 million Malaysia relocation expenses; they are not substituted for statutory profit or the unadjusted EBITDA summary. The summary FY2025 DPS 3.50 cents comprises interim 1.55 cents and final 1.95 cents proposed at the annual-report date; final dividend approval is established by the 24 April 2026 AGM results. Earlier DPS summary dashes are retained despite separate pre-IPO absolute dividend disclosures in the statutory notes.

Group changes in equity / 2024

8 metrics

Units appear below each metric. Scroll to compare years

Group changes in equity / 2024 from Annual Report 2025
Metric / unit 2024Group / Share capital / 12-month period 2024-01-01 to 2024-12-312024Group / Retained earnings / 12-month period 2024-01-01 to 2024-12-312024Group / Translation reserve / 12-month period 2024-01-01 to 2024-12-312024Group / Total equity / 12-month period 2024-01-01 to 2024-12-31 Source
Changes in equity / Group / 2024
At 1 January 2024Singapore dollars thousands 1004,158974,355 PDF p. 49
Profit for the yearSingapore dollars thousands −12,339−12,339 PDF p. 49
– Currency translation differencesSingapore dollars thousands −−(147)(147) PDF p. 49
– Currency translation differences reclassified to profit or loss on liquidation of subsidiariesSingapore dollars thousands −−(65)(65) PDF p. 49
Total comprehensive income for the yearSingapore dollars thousands −12,339(212)12,127 PDF p. 49
– Dividends declaredSingapore dollars thousands −(12,500)−(12,500) PDF p. 49
Total transactions with ownersSingapore dollars thousands −(12,500)−(12,500) PDF p. 49
At 31 December 2024Singapore dollars thousands 1003,997(115)3,982 PDF p. 49
Definitions & sources

Four available complete audited Group annual periods are FY2022–FY2025, each 1 January to 31 December. The FY2025 annual report is the first published annual report following the 4 July 2025 SGX listing. FY2022–FY2024 actual consolidated statements are in Appendix A of the official SGX final prospectus dated 27 June 2025. Appendix B unaudited pro forma FY2024 is not substituted for those actual statements. A full FY2021 audited annual statement source has not been established; the opening equity balance at 1 January 2022 is not a complete FY2021 statement set.

All monetary statement amounts are Singapore dollars thousands; basic and diluted earnings per share are Singapore cents. The latest annual report discloses financial position for Group and Company, and Group consolidated combined profit or loss and other comprehensive income, changes in equity and cash flows. Separate Company income, OCI, equity and cash-flow primary statements are not disclosed in the inspected annual report. The historical Appendix A statements are Group consolidated.

The FY2025 audit opinion is unmodified, KPMG LLP, partner Sarina Lee, dated 27 March 2026. Revenue recognition is a key audit matter; the annual auditor report discusses subscription revenue of 39,102 thousand, 69% of revenue. The historical FY2022–FY2024 Appendix A audit opinion is unmodified, KPMG LLP, Sarina Lee, dated 20 June 2025 except for Note 21 subsequent event, for which the date is 27 June 2025. Its report restricts use to inclusion in the listing prospectus.

The current annual report and historical IPO actual statements agree on FY2024 monetary values; original captions, nil rows and cash-flow row order can differ. The original IPO FY2024 income and EPS statement is retained because its EPS denominator differs from the annual comparative.

The FY2025 annual report Note 20 explicitly computes both FY2025 and FY2024 comparative basic EPS using 258,000 thousand shares, assuming that the share split and issuance of new shares had been effected for comparative purposes. EPS is 5.82 cents and 4.78 cents from profits of 15,020 and 12,339 thousand. This is the stated assumed share-capital basis; it is not labelled as an actual time-weighted share count.

The IPO Appendix A Note 19 uses the pre-invitation share capital of 225,000 thousand shares for FY2024, FY2023 and FY2022. Original EPS is respectively 5.48, 4.66 and 3.19 cents on profits of 12,339, 10,487 and 7,185 thousand. Basic and diluted EPS are equal because there are no potential dilutive ordinary shares. The annual-report financial highlights separately disclose FY2022–FY2025 EPS of 2.78, 4.06, 4.78 and 5.82 cents based on 258,000,000 shares. That reported summary is retained separately from the original audited IPO EPS basis.

On 30 May 2025 each of the original 100,000 shares was subdivided into 2,250 shares, producing 225,000,000 shares without changing the S$100,000 share capital. On 4 July 2025 the Company issued 33,000,000 new shares at S$0.87, raising 28,710 thousand gross. Equity issuance expenses were 1,450 thousand; the separately expensed listing costs were 2,930 thousand. Closing ordinary shares were 258,000,000 and share capital 27,360 thousand.

FY2025 Group dividends of 6,499 thousand include a noncash offset of 1,188 thousand against shareholder loans; cash dividends were 5,311 thousand. FY2024 declared dividends of 12,500 less loan offset 10,837 plus the prior-year dividend payable 350 reconcile to cash dividends 2,013. The 774 thousand cash receipt from shareholder loan repayments is separately an investing cash flow.

FY2025 PPE acquisition of 3,140 thousand includes noncash right-of-use assets of 2,178; cash PPE purchase is 962. FY2024 acquisition of 2,324 includes right-of-use assets of 1,943; cash PPE purchase is 381. Right-of-use assets are within PPE and are not an extra asset to add to the balance sheet.

The lease liability reconciliation separates principal payments, interest paid, exchange movements, new leases, derecognition and interest expense. For FY2025, opening 3,542 less total cash outflow 1,477 less FX 114 plus other changes 2,042 equals closing 3,993, which is 2,808 noncurrent plus 1,185 current. FY2024 closing lease liabilities are 3,542, FY2023 2,750 and FY2022 2,844.

New right-of-use assets include reinstatement costs: FY2025 55 thousand and FY2024 7 thousand. Thus FY2025 ROU additions 2,178 differ from new lease liabilities 2,123, and FY2024 ROU additions 1,943 differ from new lease liabilities 1,936. Historical FY2022 ROU additions 2,706 include reinstatement costs 111 versus new lease liabilities 2,595.

Equity rows showing total comprehensive income and total owner transactions are subtotals, rather than additional movements to sum again. Currency translation reclassification on liquidation in FY2024 is retained alongside currency translation differences. No non-controlling interest is invented for wholly owned subsidiaries.

IPO Appendix A Note 21 says the April 2025 dividend of 2,500 thousand was fully settled through a loan offset of 1,188 and cash repayment 774; those two printed amounts sum to 1,962. The annual report separately shows the 774 shareholder loan repayment as an investing cash receipt and reconciles full-year dividends using 6,499 less 1,188 equals 5,311 cash. No missing payment or balancing item is invented. The IPO subsequent-event split wording refers to subdivision into 225,000,000 shares; the annual Note 10 explicitly gives the actual 1:2,250 split from 100,000 to 225,000,000 shares.

Printed dashes are retained as printed. Unlabelled original subtotals are explicitly marked as unlabelled in source. Source links identify the original document and physical page for each row.

FY2023 reported EBITDA in the annual financial highlights is 15,137 thousand, while original operating profit 13,233 plus depreciation 1,612 and amortisation 291 equals 15,136. The printed one-thousand discrepancy is preserved without inventing a rounding or other adjustment.

The complete reported four-year financial highlights include unadjusted EBITDA, three margins, EPS on 258 million shares and dividend per share. FY2025 headline adjusted PAT and adjusted EBITDA on the separate highlights page exclude approximately 2.9 million listing and 0.1 million Malaysia relocation expenses; they are not substituted for statutory profit or the unadjusted EBITDA summary. The summary FY2025 DPS 3.50 cents comprises interim 1.55 cents and final 1.95 cents proposed at the annual-report date; final dividend approval is established by the 24 April 2026 AGM results. Earlier DPS summary dashes are retained despite separate pre-IPO absolute dividend disclosures in the statutory notes.

Reported four-year financial highlights / annual-report stated bases

20 metrics

Units appear below each metric. Scroll to compare years

Reported four-year financial highlights / annual-report stated bases from Annual Report 2025
Metric / unit 2022Group / reported financial highlights / 12-month period 2022-01-01 to 2022-12-312023Group / reported financial highlights / 12-month period 2023-01-01 to 2023-12-312024Group / reported financial highlights / 12-month period 2024-01-01 to 2024-12-312025Group / reported financial highlights / 12-month period 2025-01-01 to 2025-12-31 Source
Income Statement
RevenueSingapore dollars thousands 30,84538,06443,71356,486 PDF p. 18
Gross profitSingapore dollars thousands 26,52233,12537,41648,123 PDF p. 18
Operating profitSingapore dollars thousands 9,51513,23314,91118,938 PDF p. 18
EBITDASingapore dollars thousands 10,71815,13717,01421,156 PDF p. 18
Profit before taxSingapore dollars thousands 9,37013,00514,89819,062 PDF p. 18
Profit attributable to owners of the companySingapore dollars thousands 7,18510,48712,33915,020 PDF p. 18
Balance Sheet
Total assetsSingapore dollars thousands 28,95936,08839,66883,932 PDF p. 18
Contract liabilitiesSingapore dollars thousands 20,44022,75025,56528,967 PDF p. 18
Total liabilitiesSingapore dollars thousands 28,15731,73335,68644,046 PDF p. 18
Equity attributable to owners of the companySingapore dollars thousands 8024,3553,98239,886 PDF p. 18
Cash Flow Statement
Net cash generated from operating activitiesSingapore dollars thousands 10,68614,55018,02616,828 PDF p. 18
Net cash (used) / generated from investing activitiesSingapore dollars thousands (10,978)(7,566)(3,071)92 PDF p. 18
Net cash (used) / generated from financing activitiesSingapore dollars thousands (7,754)(1,068)(3,323)20,472 PDF p. 18
Net (decrease) / increase in cash and cash equivalentsSingapore dollars thousands (8,046)5,91611,63237,392 PDF p. 18
Cash and cash equivalents at end of yearSingapore dollars thousands 11,75817,79229,71567,284 PDF p. 18
Financial statistics
Gross profit margin (%)Percent 86.087.085.685.2 PDF p. 18
EBITDA margin (%)Percent 34.739.838.937.5 PDF p. 18
Net profit margin (%)Percent 23.327.628.226.6 PDF p. 18
Earnings per share (cents)Singapore cents per share 2.784.064.785.82 PDF p. 18
Dividend per share (cents)Singapore cents per share ---3.50 PDF p. 18
Definitions & sources

Four available complete audited Group annual periods are FY2022–FY2025, each 1 January to 31 December. The FY2025 annual report is the first published annual report following the 4 July 2025 SGX listing. FY2022–FY2024 actual consolidated statements are in Appendix A of the official SGX final prospectus dated 27 June 2025. Appendix B unaudited pro forma FY2024 is not substituted for those actual statements. A full FY2021 audited annual statement source has not been established; the opening equity balance at 1 January 2022 is not a complete FY2021 statement set.

All monetary statement amounts are Singapore dollars thousands; basic and diluted earnings per share are Singapore cents. The latest annual report discloses financial position for Group and Company, and Group consolidated combined profit or loss and other comprehensive income, changes in equity and cash flows. Separate Company income, OCI, equity and cash-flow primary statements are not disclosed in the inspected annual report. The historical Appendix A statements are Group consolidated.

The FY2025 audit opinion is unmodified, KPMG LLP, partner Sarina Lee, dated 27 March 2026. Revenue recognition is a key audit matter; the annual auditor report discusses subscription revenue of 39,102 thousand, 69% of revenue. The historical FY2022–FY2024 Appendix A audit opinion is unmodified, KPMG LLP, Sarina Lee, dated 20 June 2025 except for Note 21 subsequent event, for which the date is 27 June 2025. Its report restricts use to inclusion in the listing prospectus.

The current annual report and historical IPO actual statements agree on FY2024 monetary values; original captions, nil rows and cash-flow row order can differ. The original IPO FY2024 income and EPS statement is retained because its EPS denominator differs from the annual comparative.

The FY2025 annual report Note 20 explicitly computes both FY2025 and FY2024 comparative basic EPS using 258,000 thousand shares, assuming that the share split and issuance of new shares had been effected for comparative purposes. EPS is 5.82 cents and 4.78 cents from profits of 15,020 and 12,339 thousand. This is the stated assumed share-capital basis; it is not labelled as an actual time-weighted share count.

The IPO Appendix A Note 19 uses the pre-invitation share capital of 225,000 thousand shares for FY2024, FY2023 and FY2022. Original EPS is respectively 5.48, 4.66 and 3.19 cents on profits of 12,339, 10,487 and 7,185 thousand. Basic and diluted EPS are equal because there are no potential dilutive ordinary shares. The annual-report financial highlights separately disclose FY2022–FY2025 EPS of 2.78, 4.06, 4.78 and 5.82 cents based on 258,000,000 shares. That reported summary is retained separately from the original audited IPO EPS basis.

On 30 May 2025 each of the original 100,000 shares was subdivided into 2,250 shares, producing 225,000,000 shares without changing the S$100,000 share capital. On 4 July 2025 the Company issued 33,000,000 new shares at S$0.87, raising 28,710 thousand gross. Equity issuance expenses were 1,450 thousand; the separately expensed listing costs were 2,930 thousand. Closing ordinary shares were 258,000,000 and share capital 27,360 thousand.

FY2025 Group dividends of 6,499 thousand include a noncash offset of 1,188 thousand against shareholder loans; cash dividends were 5,311 thousand. FY2024 declared dividends of 12,500 less loan offset 10,837 plus the prior-year dividend payable 350 reconcile to cash dividends 2,013. The 774 thousand cash receipt from shareholder loan repayments is separately an investing cash flow.

FY2025 PPE acquisition of 3,140 thousand includes noncash right-of-use assets of 2,178; cash PPE purchase is 962. FY2024 acquisition of 2,324 includes right-of-use assets of 1,943; cash PPE purchase is 381. Right-of-use assets are within PPE and are not an extra asset to add to the balance sheet.

The lease liability reconciliation separates principal payments, interest paid, exchange movements, new leases, derecognition and interest expense. For FY2025, opening 3,542 less total cash outflow 1,477 less FX 114 plus other changes 2,042 equals closing 3,993, which is 2,808 noncurrent plus 1,185 current. FY2024 closing lease liabilities are 3,542, FY2023 2,750 and FY2022 2,844.

New right-of-use assets include reinstatement costs: FY2025 55 thousand and FY2024 7 thousand. Thus FY2025 ROU additions 2,178 differ from new lease liabilities 2,123, and FY2024 ROU additions 1,943 differ from new lease liabilities 1,936. Historical FY2022 ROU additions 2,706 include reinstatement costs 111 versus new lease liabilities 2,595.

Equity rows showing total comprehensive income and total owner transactions are subtotals, rather than additional movements to sum again. Currency translation reclassification on liquidation in FY2024 is retained alongside currency translation differences. No non-controlling interest is invented for wholly owned subsidiaries.

IPO Appendix A Note 21 says the April 2025 dividend of 2,500 thousand was fully settled through a loan offset of 1,188 and cash repayment 774; those two printed amounts sum to 1,962. The annual report separately shows the 774 shareholder loan repayment as an investing cash receipt and reconciles full-year dividends using 6,499 less 1,188 equals 5,311 cash. No missing payment or balancing item is invented. The IPO subsequent-event split wording refers to subdivision into 225,000,000 shares; the annual Note 10 explicitly gives the actual 1:2,250 split from 100,000 to 225,000,000 shares.

Printed dashes are retained as printed. Unlabelled original subtotals are explicitly marked as unlabelled in source. Source links identify the original document and physical page for each row.

FY2023 reported EBITDA in the annual financial highlights is 15,137 thousand, while original operating profit 13,233 plus depreciation 1,612 and amortisation 291 equals 15,136. The printed one-thousand discrepancy is preserved without inventing a rounding or other adjustment.

The complete reported four-year financial highlights include unadjusted EBITDA, three margins, EPS on 258 million shares and dividend per share. FY2025 headline adjusted PAT and adjusted EBITDA on the separate highlights page exclude approximately 2.9 million listing and 0.1 million Malaysia relocation expenses; they are not substituted for statutory profit or the unadjusted EBITDA summary. The summary FY2025 DPS 3.50 cents comprises interim 1.55 cents and final 1.95 cents proposed at the annual-report date; final dividend approval is established by the 24 April 2026 AGM results. Earlier DPS summary dashes are retained despite separate pre-IPO absolute dividend disclosures in the statutory notes.

Historical Group statement of financial position / IPO audited Appendix A

25 metrics

Units appear below each metric. Scroll to compare years

Historical Group statement of financial position / IPO audited Appendix A from Annual Report 2025
Metric / unit 2023Group / audited actual IPO Appendix A / as at 2023-12-312022Group / audited actual IPO Appendix A / as at 2022-12-31 Source
Non-current assets
Property, plant and equipmentSingapore dollars thousands 3,8053,544 PDF p. 220
Intangible assetsSingapore dollars thousands 554586 PDF p. 220
Deferred tax assetsSingapore dollars thousands 1,110834 PDF p. 220
Total non-current assets (unlabelled in source)Singapore dollars thousands 5,4694,964 PDF p. 220
Current assets
InventoriesSingapore dollars thousands 14384 PDF p. 220
Trade and other receivablesSingapore dollars thousands 12,68412,153 PDF p. 220
Cash and cash equivalentsSingapore dollars thousands 17,79211,758 PDF p. 220
Total current assets (unlabelled in source)Singapore dollars thousands 30,61923,995 PDF p. 220
Total assetsSingapore dollars thousands 36,08828,959 PDF p. 220
Equity
Share capitalSingapore dollars thousands 100100 PDF p. 220
Retained earningsSingapore dollars thousands 4,158671 PDF p. 220
Translation reserveSingapore dollars thousands 9731 PDF p. 220
Equity attributable to the owners of the CompanySingapore dollars thousands 4,355802 PDF p. 220
Non-current liabilities
Contract liabilitiesSingapore dollars thousands 1,077599 PDF p. 220
Lease liabilitiesSingapore dollars thousands 1,6881,965 PDF p. 220
Provision for reinstatement costsSingapore dollars thousands 116111 PDF p. 220
Deferred tax liabilitiesSingapore dollars thousands 2727 PDF p. 220
Total non-current liabilities (unlabelled in source)Singapore dollars thousands 2,9082,702 PDF p. 220
Current liabilities
Trade and other payablesSingapore dollars thousands 3,3802,907 PDF p. 220
Contract liabilitiesSingapore dollars thousands 21,67319,841 PDF p. 220
Lease liabilitiesSingapore dollars thousands 1,062879 PDF p. 220
Current tax liabilitiesSingapore dollars thousands 2,7101,828 PDF p. 220
Total current liabilities (unlabelled in source)Singapore dollars thousands 28,82525,455 PDF p. 220
Total liabilitiesSingapore dollars thousands 31,73328,157 PDF p. 220
Total equity and liabilitiesSingapore dollars thousands 36,08828,959 PDF p. 220
Definitions & sources

Four available complete audited Group annual periods are FY2022–FY2025, each 1 January to 31 December. The FY2025 annual report is the first published annual report following the 4 July 2025 SGX listing. FY2022–FY2024 actual consolidated statements are in Appendix A of the official SGX final prospectus dated 27 June 2025. Appendix B unaudited pro forma FY2024 is not substituted for those actual statements. A full FY2021 audited annual statement source has not been established; the opening equity balance at 1 January 2022 is not a complete FY2021 statement set.

All monetary statement amounts are Singapore dollars thousands; basic and diluted earnings per share are Singapore cents. The latest annual report discloses financial position for Group and Company, and Group consolidated combined profit or loss and other comprehensive income, changes in equity and cash flows. Separate Company income, OCI, equity and cash-flow primary statements are not disclosed in the inspected annual report. The historical Appendix A statements are Group consolidated.

The FY2025 audit opinion is unmodified, KPMG LLP, partner Sarina Lee, dated 27 March 2026. Revenue recognition is a key audit matter; the annual auditor report discusses subscription revenue of 39,102 thousand, 69% of revenue. The historical FY2022–FY2024 Appendix A audit opinion is unmodified, KPMG LLP, Sarina Lee, dated 20 June 2025 except for Note 21 subsequent event, for which the date is 27 June 2025. Its report restricts use to inclusion in the listing prospectus.

The current annual report and historical IPO actual statements agree on FY2024 monetary values; original captions, nil rows and cash-flow row order can differ. The original IPO FY2024 income and EPS statement is retained because its EPS denominator differs from the annual comparative.

The FY2025 annual report Note 20 explicitly computes both FY2025 and FY2024 comparative basic EPS using 258,000 thousand shares, assuming that the share split and issuance of new shares had been effected for comparative purposes. EPS is 5.82 cents and 4.78 cents from profits of 15,020 and 12,339 thousand. This is the stated assumed share-capital basis; it is not labelled as an actual time-weighted share count.

The IPO Appendix A Note 19 uses the pre-invitation share capital of 225,000 thousand shares for FY2024, FY2023 and FY2022. Original EPS is respectively 5.48, 4.66 and 3.19 cents on profits of 12,339, 10,487 and 7,185 thousand. Basic and diluted EPS are equal because there are no potential dilutive ordinary shares. The annual-report financial highlights separately disclose FY2022–FY2025 EPS of 2.78, 4.06, 4.78 and 5.82 cents based on 258,000,000 shares. That reported summary is retained separately from the original audited IPO EPS basis.

On 30 May 2025 each of the original 100,000 shares was subdivided into 2,250 shares, producing 225,000,000 shares without changing the S$100,000 share capital. On 4 July 2025 the Company issued 33,000,000 new shares at S$0.87, raising 28,710 thousand gross. Equity issuance expenses were 1,450 thousand; the separately expensed listing costs were 2,930 thousand. Closing ordinary shares were 258,000,000 and share capital 27,360 thousand.

FY2025 Group dividends of 6,499 thousand include a noncash offset of 1,188 thousand against shareholder loans; cash dividends were 5,311 thousand. FY2024 declared dividends of 12,500 less loan offset 10,837 plus the prior-year dividend payable 350 reconcile to cash dividends 2,013. The 774 thousand cash receipt from shareholder loan repayments is separately an investing cash flow.

FY2025 PPE acquisition of 3,140 thousand includes noncash right-of-use assets of 2,178; cash PPE purchase is 962. FY2024 acquisition of 2,324 includes right-of-use assets of 1,943; cash PPE purchase is 381. Right-of-use assets are within PPE and are not an extra asset to add to the balance sheet.

The lease liability reconciliation separates principal payments, interest paid, exchange movements, new leases, derecognition and interest expense. For FY2025, opening 3,542 less total cash outflow 1,477 less FX 114 plus other changes 2,042 equals closing 3,993, which is 2,808 noncurrent plus 1,185 current. FY2024 closing lease liabilities are 3,542, FY2023 2,750 and FY2022 2,844.

New right-of-use assets include reinstatement costs: FY2025 55 thousand and FY2024 7 thousand. Thus FY2025 ROU additions 2,178 differ from new lease liabilities 2,123, and FY2024 ROU additions 1,943 differ from new lease liabilities 1,936. Historical FY2022 ROU additions 2,706 include reinstatement costs 111 versus new lease liabilities 2,595.

Equity rows showing total comprehensive income and total owner transactions are subtotals, rather than additional movements to sum again. Currency translation reclassification on liquidation in FY2024 is retained alongside currency translation differences. No non-controlling interest is invented for wholly owned subsidiaries.

IPO Appendix A Note 21 says the April 2025 dividend of 2,500 thousand was fully settled through a loan offset of 1,188 and cash repayment 774; those two printed amounts sum to 1,962. The annual report separately shows the 774 shareholder loan repayment as an investing cash receipt and reconciles full-year dividends using 6,499 less 1,188 equals 5,311 cash. No missing payment or balancing item is invented. The IPO subsequent-event split wording refers to subdivision into 225,000,000 shares; the annual Note 10 explicitly gives the actual 1:2,250 split from 100,000 to 225,000,000 shares.

Printed dashes are retained as printed. Unlabelled original subtotals are explicitly marked as unlabelled in source. Source links identify the original document and physical page for each row.

FY2023 reported EBITDA in the annual financial highlights is 15,137 thousand, while original operating profit 13,233 plus depreciation 1,612 and amortisation 291 equals 15,136. The printed one-thousand discrepancy is preserved without inventing a rounding or other adjustment.

The complete reported four-year financial highlights include unadjusted EBITDA, three margins, EPS on 258 million shares and dividend per share. FY2025 headline adjusted PAT and adjusted EBITDA on the separate highlights page exclude approximately 2.9 million listing and 0.1 million Malaysia relocation expenses; they are not substituted for statutory profit or the unadjusted EBITDA summary. The summary FY2025 DPS 3.50 cents comprises interim 1.55 cents and final 1.95 cents proposed at the annual-report date; final dividend approval is established by the 24 April 2026 AGM results. Earlier DPS summary dashes are retained despite separate pre-IPO absolute dividend disclosures in the statutory notes.

Historical Group combined profit or loss and OCI / IPO audited Appendix A

20 metrics

Units appear below each metric. Scroll to compare years

Historical Group combined profit or loss and OCI / IPO audited Appendix A from Annual Report 2025
Metric / unit 2023Group / audited actual IPO Appendix A / 12-month period 2023-01-01 to 2023-12-312022Group / audited actual IPO Appendix A / 12-month period 2022-01-01 to 2022-12-31 Source
income
RevenueSingapore dollars thousands 38,06430,845 PDF p. 221
Cost of salesSingapore dollars thousands (4,939)(4,323) PDF p. 221
Gross profitSingapore dollars thousands 33,12526,522 PDF p. 221
Other incomeSingapore dollars thousands 160368 PDF p. 221
Selling and distribution expensesSingapore dollars thousands (8,056)(7,152) PDF p. 221
Administrative expensesSingapore dollars thousands (8,419)(6,337) PDF p. 221
Research and development expensesSingapore dollars thousands (2,860)(2,743) PDF p. 221
Other expensesSingapore dollars thousands (717)(1,143) PDF p. 221
Operating profitSingapore dollars thousands 13,2339,515 PDF p. 221
Finance incomeSingapore dollars thousands 174 PDF p. 221
Finance costsSingapore dollars thousands (245)(149) PDF p. 221
Net finance costsSingapore dollars thousands (228)(145) PDF p. 221
Profit before taxSingapore dollars thousands 13,0059,370 PDF p. 221
Tax expenseSingapore dollars thousands (2,518)(2,185) PDF p. 221
Profit for the yearSingapore dollars thousands 10,4877,185 PDF p. 221
Foreign operations:
– Currency translation differencesSingapore dollars thousands 6634 PDF p. 221
– Currency translation differences reclassified to profit or loss on liquidation of subsidiariesSingapore dollars thousands −− PDF p. 221
Total comprehensive income
Total comprehensive income for the year attributable to the Owners of the CompanySingapore dollars thousands 10,5537,219 PDF p. 221
Earnings per share attributable to the ordinary equity holders of the Company during the financial year
Basic earnings per share (cents)Singapore cents per share 4.663.19 PDF p. 221
Diluted earnings per share (cents)Singapore cents per share 4.663.19 PDF p. 221
Definitions & sources

Four available complete audited Group annual periods are FY2022–FY2025, each 1 January to 31 December. The FY2025 annual report is the first published annual report following the 4 July 2025 SGX listing. FY2022–FY2024 actual consolidated statements are in Appendix A of the official SGX final prospectus dated 27 June 2025. Appendix B unaudited pro forma FY2024 is not substituted for those actual statements. A full FY2021 audited annual statement source has not been established; the opening equity balance at 1 January 2022 is not a complete FY2021 statement set.

All monetary statement amounts are Singapore dollars thousands; basic and diluted earnings per share are Singapore cents. The latest annual report discloses financial position for Group and Company, and Group consolidated combined profit or loss and other comprehensive income, changes in equity and cash flows. Separate Company income, OCI, equity and cash-flow primary statements are not disclosed in the inspected annual report. The historical Appendix A statements are Group consolidated.

The FY2025 audit opinion is unmodified, KPMG LLP, partner Sarina Lee, dated 27 March 2026. Revenue recognition is a key audit matter; the annual auditor report discusses subscription revenue of 39,102 thousand, 69% of revenue. The historical FY2022–FY2024 Appendix A audit opinion is unmodified, KPMG LLP, Sarina Lee, dated 20 June 2025 except for Note 21 subsequent event, for which the date is 27 June 2025. Its report restricts use to inclusion in the listing prospectus.

The current annual report and historical IPO actual statements agree on FY2024 monetary values; original captions, nil rows and cash-flow row order can differ. The original IPO FY2024 income and EPS statement is retained because its EPS denominator differs from the annual comparative.

The FY2025 annual report Note 20 explicitly computes both FY2025 and FY2024 comparative basic EPS using 258,000 thousand shares, assuming that the share split and issuance of new shares had been effected for comparative purposes. EPS is 5.82 cents and 4.78 cents from profits of 15,020 and 12,339 thousand. This is the stated assumed share-capital basis; it is not labelled as an actual time-weighted share count.

The IPO Appendix A Note 19 uses the pre-invitation share capital of 225,000 thousand shares for FY2024, FY2023 and FY2022. Original EPS is respectively 5.48, 4.66 and 3.19 cents on profits of 12,339, 10,487 and 7,185 thousand. Basic and diluted EPS are equal because there are no potential dilutive ordinary shares. The annual-report financial highlights separately disclose FY2022–FY2025 EPS of 2.78, 4.06, 4.78 and 5.82 cents based on 258,000,000 shares. That reported summary is retained separately from the original audited IPO EPS basis.

On 30 May 2025 each of the original 100,000 shares was subdivided into 2,250 shares, producing 225,000,000 shares without changing the S$100,000 share capital. On 4 July 2025 the Company issued 33,000,000 new shares at S$0.87, raising 28,710 thousand gross. Equity issuance expenses were 1,450 thousand; the separately expensed listing costs were 2,930 thousand. Closing ordinary shares were 258,000,000 and share capital 27,360 thousand.

FY2025 Group dividends of 6,499 thousand include a noncash offset of 1,188 thousand against shareholder loans; cash dividends were 5,311 thousand. FY2024 declared dividends of 12,500 less loan offset 10,837 plus the prior-year dividend payable 350 reconcile to cash dividends 2,013. The 774 thousand cash receipt from shareholder loan repayments is separately an investing cash flow.

FY2025 PPE acquisition of 3,140 thousand includes noncash right-of-use assets of 2,178; cash PPE purchase is 962. FY2024 acquisition of 2,324 includes right-of-use assets of 1,943; cash PPE purchase is 381. Right-of-use assets are within PPE and are not an extra asset to add to the balance sheet.

The lease liability reconciliation separates principal payments, interest paid, exchange movements, new leases, derecognition and interest expense. For FY2025, opening 3,542 less total cash outflow 1,477 less FX 114 plus other changes 2,042 equals closing 3,993, which is 2,808 noncurrent plus 1,185 current. FY2024 closing lease liabilities are 3,542, FY2023 2,750 and FY2022 2,844.

New right-of-use assets include reinstatement costs: FY2025 55 thousand and FY2024 7 thousand. Thus FY2025 ROU additions 2,178 differ from new lease liabilities 2,123, and FY2024 ROU additions 1,943 differ from new lease liabilities 1,936. Historical FY2022 ROU additions 2,706 include reinstatement costs 111 versus new lease liabilities 2,595.

Equity rows showing total comprehensive income and total owner transactions are subtotals, rather than additional movements to sum again. Currency translation reclassification on liquidation in FY2024 is retained alongside currency translation differences. No non-controlling interest is invented for wholly owned subsidiaries.

IPO Appendix A Note 21 says the April 2025 dividend of 2,500 thousand was fully settled through a loan offset of 1,188 and cash repayment 774; those two printed amounts sum to 1,962. The annual report separately shows the 774 shareholder loan repayment as an investing cash receipt and reconciles full-year dividends using 6,499 less 1,188 equals 5,311 cash. No missing payment or balancing item is invented. The IPO subsequent-event split wording refers to subdivision into 225,000,000 shares; the annual Note 10 explicitly gives the actual 1:2,250 split from 100,000 to 225,000,000 shares.

Printed dashes are retained as printed. Unlabelled original subtotals are explicitly marked as unlabelled in source. Source links identify the original document and physical page for each row.

FY2023 reported EBITDA in the annual financial highlights is 15,137 thousand, while original operating profit 13,233 plus depreciation 1,612 and amortisation 291 equals 15,136. The printed one-thousand discrepancy is preserved without inventing a rounding or other adjustment.

The complete reported four-year financial highlights include unadjusted EBITDA, three margins, EPS on 258 million shares and dividend per share. FY2025 headline adjusted PAT and adjusted EBITDA on the separate highlights page exclude approximately 2.9 million listing and 0.1 million Malaysia relocation expenses; they are not substituted for statutory profit or the unadjusted EBITDA summary. The summary FY2025 DPS 3.50 cents comprises interim 1.55 cents and final 1.95 cents proposed at the annual-report date; final dividend approval is established by the 24 April 2026 AGM results. Earlier DPS summary dashes are retained despite separate pre-IPO absolute dividend disclosures in the statutory notes.

Historical Group consolidated cash flows / IPO audited Appendix A

34 metrics

Units appear below each metric. Scroll to compare years

Historical Group consolidated cash flows / IPO audited Appendix A from Annual Report 2025
Metric / unit 2023Group / audited actual IPO Appendix A / 12-month period 2023-01-01 to 2023-12-312022Group / audited actual IPO Appendix A / 12-month period 2022-01-01 to 2022-12-31 Source
Cash flows from operating activities
Profit before taxSingapore dollars thousands 13,0059,370 PDF p. 224
Adjustments for:
Depreciation of property, plant and equipmentSingapore dollars thousands 1,612971 PDF p. 224
Amortisation of intangible assetsSingapore dollars thousands 291232 PDF p. 224
Loss on property, plant and equipment written offSingapore dollars thousands 6957 PDF p. 224
Loss on intangible assets written offSingapore dollars thousands −− PDF p. 224
Gain on derecognition of leaseSingapore dollars thousands −(22) PDF p. 224
Gain on liquidation of subsidiariesSingapore dollars thousands −− PDF p. 224
Impairment loss/(Reversal of impairment loss) on trade receivablesSingapore dollars thousands (32)161 PDF p. 224
Bad debts written offSingapore dollars thousands −78 PDF p. 224
Interest incomeSingapore dollars thousands (17)(4) PDF p. 224
Interest on lease liabilitiesSingapore dollars thousands 13548 PDF p. 224
Unwinding of discount on provision for reinstatement costsSingapore dollars thousands 5− PDF p. 224
Operating cash before changes in working capital (unlabelled in source)Singapore dollars thousands 15,06810,891 PDF p. 224
Changes in:
InventoriesSingapore dollars thousands (58)(4) PDF p. 224
Trade and other receivablesSingapore dollars thousands (926)(909) PDF p. 224
Trade and other payablesSingapore dollars thousands 123674 PDF p. 224
Contract liabilitiesSingapore dollars thousands 2,3102,530 PDF p. 224
Cash flows from operating activities
Cash generated from operationsSingapore dollars thousands 16,51713,182 PDF p. 224
Tax paidSingapore dollars thousands (1,967)(2,496) PDF p. 224
Net cash generated from operating activitiesSingapore dollars thousands 14,55010,686 PDF p. 224
Cash flows from investing activities
Purchase of property, plant and equipmentSingapore dollars thousands (1,099)(455) PDF p. 224
Purchase of intangible assetsSingapore dollars thousands (13)(10) PDF p. 224
Capitalisation of development costsSingapore dollars thousands (247)(292) PDF p. 224
Receipt of interest incomeSingapore dollars thousands 174 PDF p. 224
Loans to shareholdersSingapore dollars thousands (6,224)(10,225) PDF p. 224
Net cash used in investing activitiesSingapore dollars thousands (7,566)(10,978) PDF p. 224
Cash flows from financing activities
Payment of lease liabilitiesSingapore dollars thousands (933)(606) PDF p. 224
Interest paidSingapore dollars thousands (135)(48) PDF p. 224
Dividends paidSingapore dollars thousands −(7,100) PDF p. 224
Net cash used in financing activitiesSingapore dollars thousands (1,068)(7,754) PDF p. 224
Cash and cash equivalents reconciliation
Net increase/(decrease) in cash and cash equivalentsSingapore dollars thousands 5,916(8,046) PDF p. 224
Cash and cash equivalents at 1 JanuarySingapore dollars thousands 11,75819,688 PDF p. 224
Effect of exchange rates fluctuations on cash and cash equivalentsSingapore dollars thousands 118116 PDF p. 224
Cash and cash equivalents at 31 DecemberSingapore dollars thousands 17,79211,758 PDF p. 224
Definitions & sources

Four available complete audited Group annual periods are FY2022–FY2025, each 1 January to 31 December. The FY2025 annual report is the first published annual report following the 4 July 2025 SGX listing. FY2022–FY2024 actual consolidated statements are in Appendix A of the official SGX final prospectus dated 27 June 2025. Appendix B unaudited pro forma FY2024 is not substituted for those actual statements. A full FY2021 audited annual statement source has not been established; the opening equity balance at 1 January 2022 is not a complete FY2021 statement set.

All monetary statement amounts are Singapore dollars thousands; basic and diluted earnings per share are Singapore cents. The latest annual report discloses financial position for Group and Company, and Group consolidated combined profit or loss and other comprehensive income, changes in equity and cash flows. Separate Company income, OCI, equity and cash-flow primary statements are not disclosed in the inspected annual report. The historical Appendix A statements are Group consolidated.

The FY2025 audit opinion is unmodified, KPMG LLP, partner Sarina Lee, dated 27 March 2026. Revenue recognition is a key audit matter; the annual auditor report discusses subscription revenue of 39,102 thousand, 69% of revenue. The historical FY2022–FY2024 Appendix A audit opinion is unmodified, KPMG LLP, Sarina Lee, dated 20 June 2025 except for Note 21 subsequent event, for which the date is 27 June 2025. Its report restricts use to inclusion in the listing prospectus.

The current annual report and historical IPO actual statements agree on FY2024 monetary values; original captions, nil rows and cash-flow row order can differ. The original IPO FY2024 income and EPS statement is retained because its EPS denominator differs from the annual comparative.

The FY2025 annual report Note 20 explicitly computes both FY2025 and FY2024 comparative basic EPS using 258,000 thousand shares, assuming that the share split and issuance of new shares had been effected for comparative purposes. EPS is 5.82 cents and 4.78 cents from profits of 15,020 and 12,339 thousand. This is the stated assumed share-capital basis; it is not labelled as an actual time-weighted share count.

The IPO Appendix A Note 19 uses the pre-invitation share capital of 225,000 thousand shares for FY2024, FY2023 and FY2022. Original EPS is respectively 5.48, 4.66 and 3.19 cents on profits of 12,339, 10,487 and 7,185 thousand. Basic and diluted EPS are equal because there are no potential dilutive ordinary shares. The annual-report financial highlights separately disclose FY2022–FY2025 EPS of 2.78, 4.06, 4.78 and 5.82 cents based on 258,000,000 shares. That reported summary is retained separately from the original audited IPO EPS basis.

On 30 May 2025 each of the original 100,000 shares was subdivided into 2,250 shares, producing 225,000,000 shares without changing the S$100,000 share capital. On 4 July 2025 the Company issued 33,000,000 new shares at S$0.87, raising 28,710 thousand gross. Equity issuance expenses were 1,450 thousand; the separately expensed listing costs were 2,930 thousand. Closing ordinary shares were 258,000,000 and share capital 27,360 thousand.

FY2025 Group dividends of 6,499 thousand include a noncash offset of 1,188 thousand against shareholder loans; cash dividends were 5,311 thousand. FY2024 declared dividends of 12,500 less loan offset 10,837 plus the prior-year dividend payable 350 reconcile to cash dividends 2,013. The 774 thousand cash receipt from shareholder loan repayments is separately an investing cash flow.

FY2025 PPE acquisition of 3,140 thousand includes noncash right-of-use assets of 2,178; cash PPE purchase is 962. FY2024 acquisition of 2,324 includes right-of-use assets of 1,943; cash PPE purchase is 381. Right-of-use assets are within PPE and are not an extra asset to add to the balance sheet.

The lease liability reconciliation separates principal payments, interest paid, exchange movements, new leases, derecognition and interest expense. For FY2025, opening 3,542 less total cash outflow 1,477 less FX 114 plus other changes 2,042 equals closing 3,993, which is 2,808 noncurrent plus 1,185 current. FY2024 closing lease liabilities are 3,542, FY2023 2,750 and FY2022 2,844.

New right-of-use assets include reinstatement costs: FY2025 55 thousand and FY2024 7 thousand. Thus FY2025 ROU additions 2,178 differ from new lease liabilities 2,123, and FY2024 ROU additions 1,943 differ from new lease liabilities 1,936. Historical FY2022 ROU additions 2,706 include reinstatement costs 111 versus new lease liabilities 2,595.

Equity rows showing total comprehensive income and total owner transactions are subtotals, rather than additional movements to sum again. Currency translation reclassification on liquidation in FY2024 is retained alongside currency translation differences. No non-controlling interest is invented for wholly owned subsidiaries.

IPO Appendix A Note 21 says the April 2025 dividend of 2,500 thousand was fully settled through a loan offset of 1,188 and cash repayment 774; those two printed amounts sum to 1,962. The annual report separately shows the 774 shareholder loan repayment as an investing cash receipt and reconciles full-year dividends using 6,499 less 1,188 equals 5,311 cash. No missing payment or balancing item is invented. The IPO subsequent-event split wording refers to subdivision into 225,000,000 shares; the annual Note 10 explicitly gives the actual 1:2,250 split from 100,000 to 225,000,000 shares.

Printed dashes are retained as printed. Unlabelled original subtotals are explicitly marked as unlabelled in source. Source links identify the original document and physical page for each row.

FY2023 reported EBITDA in the annual financial highlights is 15,137 thousand, while original operating profit 13,233 plus depreciation 1,612 and amortisation 291 equals 15,136. The printed one-thousand discrepancy is preserved without inventing a rounding or other adjustment.

The complete reported four-year financial highlights include unadjusted EBITDA, three margins, EPS on 258 million shares and dividend per share. FY2025 headline adjusted PAT and adjusted EBITDA on the separate highlights page exclude approximately 2.9 million listing and 0.1 million Malaysia relocation expenses; they are not substituted for statutory profit or the unadjusted EBITDA summary. The summary FY2025 DPS 3.50 cents comprises interim 1.55 cents and final 1.95 cents proposed at the annual-report date; final dividend approval is established by the 24 April 2026 AGM results. Earlier DPS summary dashes are retained despite separate pre-IPO absolute dividend disclosures in the statutory notes.

Historical Group lease liability financing reconciliation / IPO audited Appendix A

11 metrics

Units appear below each metric. Scroll to compare years

Historical Group lease liability financing reconciliation / IPO audited Appendix A from Annual Report 2025
Metric / unit 2023Group / audited actual IPO Appendix A / 12-month period 2023-01-01 to 2023-12-312022Group / audited actual IPO Appendix A / 12-month period 2022-01-01 to 2022-12-31 Source
finance
At 1 JanuarySingapore dollars thousands 2,8441,086 PDF p. 248
Changes in financing cash flows
Payment of lease liabilitiesSingapore dollars thousands (933)(606) PDF p. 248
finance
Interest paidSingapore dollars thousands (135)(48) PDF p. 248
Total changes from financing cash flowsSingapore dollars thousands (1,068)(654) PDF p. 248
Effect of changes in foreign exchange ratesSingapore dollars thousands (91)(47) PDF p. 248
Liability-related other changes
New leasesSingapore dollars thousands 9302,595 PDF p. 248
finance
Modification of lease contractsSingapore dollars thousands –79 PDF p. 248
Liability-related other changes
Derecognition of lease liabilitiesSingapore dollars thousands –(263) PDF p. 248
finance
Interest expenseSingapore dollars thousands 13548 PDF p. 248
Total liability-related other changesSingapore dollars thousands 1,0652,459 PDF p. 248
Balance at 31 DecemberSingapore dollars thousands 2,7502,844 PDF p. 248
Definitions & sources

Four available complete audited Group annual periods are FY2022–FY2025, each 1 January to 31 December. The FY2025 annual report is the first published annual report following the 4 July 2025 SGX listing. FY2022–FY2024 actual consolidated statements are in Appendix A of the official SGX final prospectus dated 27 June 2025. Appendix B unaudited pro forma FY2024 is not substituted for those actual statements. A full FY2021 audited annual statement source has not been established; the opening equity balance at 1 January 2022 is not a complete FY2021 statement set.

All monetary statement amounts are Singapore dollars thousands; basic and diluted earnings per share are Singapore cents. The latest annual report discloses financial position for Group and Company, and Group consolidated combined profit or loss and other comprehensive income, changes in equity and cash flows. Separate Company income, OCI, equity and cash-flow primary statements are not disclosed in the inspected annual report. The historical Appendix A statements are Group consolidated.

The FY2025 audit opinion is unmodified, KPMG LLP, partner Sarina Lee, dated 27 March 2026. Revenue recognition is a key audit matter; the annual auditor report discusses subscription revenue of 39,102 thousand, 69% of revenue. The historical FY2022–FY2024 Appendix A audit opinion is unmodified, KPMG LLP, Sarina Lee, dated 20 June 2025 except for Note 21 subsequent event, for which the date is 27 June 2025. Its report restricts use to inclusion in the listing prospectus.

The current annual report and historical IPO actual statements agree on FY2024 monetary values; original captions, nil rows and cash-flow row order can differ. The original IPO FY2024 income and EPS statement is retained because its EPS denominator differs from the annual comparative.

The FY2025 annual report Note 20 explicitly computes both FY2025 and FY2024 comparative basic EPS using 258,000 thousand shares, assuming that the share split and issuance of new shares had been effected for comparative purposes. EPS is 5.82 cents and 4.78 cents from profits of 15,020 and 12,339 thousand. This is the stated assumed share-capital basis; it is not labelled as an actual time-weighted share count.

The IPO Appendix A Note 19 uses the pre-invitation share capital of 225,000 thousand shares for FY2024, FY2023 and FY2022. Original EPS is respectively 5.48, 4.66 and 3.19 cents on profits of 12,339, 10,487 and 7,185 thousand. Basic and diluted EPS are equal because there are no potential dilutive ordinary shares. The annual-report financial highlights separately disclose FY2022–FY2025 EPS of 2.78, 4.06, 4.78 and 5.82 cents based on 258,000,000 shares. That reported summary is retained separately from the original audited IPO EPS basis.

On 30 May 2025 each of the original 100,000 shares was subdivided into 2,250 shares, producing 225,000,000 shares without changing the S$100,000 share capital. On 4 July 2025 the Company issued 33,000,000 new shares at S$0.87, raising 28,710 thousand gross. Equity issuance expenses were 1,450 thousand; the separately expensed listing costs were 2,930 thousand. Closing ordinary shares were 258,000,000 and share capital 27,360 thousand.

FY2025 Group dividends of 6,499 thousand include a noncash offset of 1,188 thousand against shareholder loans; cash dividends were 5,311 thousand. FY2024 declared dividends of 12,500 less loan offset 10,837 plus the prior-year dividend payable 350 reconcile to cash dividends 2,013. The 774 thousand cash receipt from shareholder loan repayments is separately an investing cash flow.

FY2025 PPE acquisition of 3,140 thousand includes noncash right-of-use assets of 2,178; cash PPE purchase is 962. FY2024 acquisition of 2,324 includes right-of-use assets of 1,943; cash PPE purchase is 381. Right-of-use assets are within PPE and are not an extra asset to add to the balance sheet.

The lease liability reconciliation separates principal payments, interest paid, exchange movements, new leases, derecognition and interest expense. For FY2025, opening 3,542 less total cash outflow 1,477 less FX 114 plus other changes 2,042 equals closing 3,993, which is 2,808 noncurrent plus 1,185 current. FY2024 closing lease liabilities are 3,542, FY2023 2,750 and FY2022 2,844.

New right-of-use assets include reinstatement costs: FY2025 55 thousand and FY2024 7 thousand. Thus FY2025 ROU additions 2,178 differ from new lease liabilities 2,123, and FY2024 ROU additions 1,943 differ from new lease liabilities 1,936. Historical FY2022 ROU additions 2,706 include reinstatement costs 111 versus new lease liabilities 2,595.

Equity rows showing total comprehensive income and total owner transactions are subtotals, rather than additional movements to sum again. Currency translation reclassification on liquidation in FY2024 is retained alongside currency translation differences. No non-controlling interest is invented for wholly owned subsidiaries.

IPO Appendix A Note 21 says the April 2025 dividend of 2,500 thousand was fully settled through a loan offset of 1,188 and cash repayment 774; those two printed amounts sum to 1,962. The annual report separately shows the 774 shareholder loan repayment as an investing cash receipt and reconciles full-year dividends using 6,499 less 1,188 equals 5,311 cash. No missing payment or balancing item is invented. The IPO subsequent-event split wording refers to subdivision into 225,000,000 shares; the annual Note 10 explicitly gives the actual 1:2,250 split from 100,000 to 225,000,000 shares.

Printed dashes are retained as printed. Unlabelled original subtotals are explicitly marked as unlabelled in source. Source links identify the original document and physical page for each row.

FY2023 reported EBITDA in the annual financial highlights is 15,137 thousand, while original operating profit 13,233 plus depreciation 1,612 and amortisation 291 equals 15,136. The printed one-thousand discrepancy is preserved without inventing a rounding or other adjustment.

The complete reported four-year financial highlights include unadjusted EBITDA, three margins, EPS on 258 million shares and dividend per share. FY2025 headline adjusted PAT and adjusted EBITDA on the separate highlights page exclude approximately 2.9 million listing and 0.1 million Malaysia relocation expenses; they are not substituted for statutory profit or the unadjusted EBITDA summary. The summary FY2025 DPS 3.50 cents comprises interim 1.55 cents and final 1.95 cents proposed at the annual-report date; final dividend approval is established by the 24 April 2026 AGM results. Earlier DPS summary dashes are retained despite separate pre-IPO absolute dividend disclosures in the statutory notes.

Group changes in equity / 2023

7 metrics

Units appear below each metric. Scroll to compare years

Group changes in equity / 2023 from Annual Report 2025
Metric / unit 2023Group / Share capital / 12-month period 2023-01-01 to 2023-12-312023Group / Retained earnings / 12-month period 2023-01-01 to 2023-12-312023Group / Translation reserve / 12-month period 2023-01-01 to 2023-12-312023Group / Total equity / 12-month period 2023-01-01 to 2023-12-31 Source
Changes in equity / Group / 2023
At 1 January 2023Singapore dollars thousands 10067131802 PDF p. 222
Profit for the yearSingapore dollars thousands −10,487−10,487 PDF p. 222
– Currency translation differencesSingapore dollars thousands −−6666 PDF p. 222
Total comprehensive income for the yearSingapore dollars thousands −10,4876610,553 PDF p. 222
Dividends declaredSingapore dollars thousands −(7,000)−(7,000) PDF p. 222
Total transactions with ownersSingapore dollars thousands −(7,000)−(7,000) PDF p. 222
At 31 December 2023Singapore dollars thousands 1004,158974,355 PDF p. 222
Definitions & sources

Four available complete audited Group annual periods are FY2022–FY2025, each 1 January to 31 December. The FY2025 annual report is the first published annual report following the 4 July 2025 SGX listing. FY2022–FY2024 actual consolidated statements are in Appendix A of the official SGX final prospectus dated 27 June 2025. Appendix B unaudited pro forma FY2024 is not substituted for those actual statements. A full FY2021 audited annual statement source has not been established; the opening equity balance at 1 January 2022 is not a complete FY2021 statement set.

All monetary statement amounts are Singapore dollars thousands; basic and diluted earnings per share are Singapore cents. The latest annual report discloses financial position for Group and Company, and Group consolidated combined profit or loss and other comprehensive income, changes in equity and cash flows. Separate Company income, OCI, equity and cash-flow primary statements are not disclosed in the inspected annual report. The historical Appendix A statements are Group consolidated.

The FY2025 audit opinion is unmodified, KPMG LLP, partner Sarina Lee, dated 27 March 2026. Revenue recognition is a key audit matter; the annual auditor report discusses subscription revenue of 39,102 thousand, 69% of revenue. The historical FY2022–FY2024 Appendix A audit opinion is unmodified, KPMG LLP, Sarina Lee, dated 20 June 2025 except for Note 21 subsequent event, for which the date is 27 June 2025. Its report restricts use to inclusion in the listing prospectus.

The current annual report and historical IPO actual statements agree on FY2024 monetary values; original captions, nil rows and cash-flow row order can differ. The original IPO FY2024 income and EPS statement is retained because its EPS denominator differs from the annual comparative.

The FY2025 annual report Note 20 explicitly computes both FY2025 and FY2024 comparative basic EPS using 258,000 thousand shares, assuming that the share split and issuance of new shares had been effected for comparative purposes. EPS is 5.82 cents and 4.78 cents from profits of 15,020 and 12,339 thousand. This is the stated assumed share-capital basis; it is not labelled as an actual time-weighted share count.

The IPO Appendix A Note 19 uses the pre-invitation share capital of 225,000 thousand shares for FY2024, FY2023 and FY2022. Original EPS is respectively 5.48, 4.66 and 3.19 cents on profits of 12,339, 10,487 and 7,185 thousand. Basic and diluted EPS are equal because there are no potential dilutive ordinary shares. The annual-report financial highlights separately disclose FY2022–FY2025 EPS of 2.78, 4.06, 4.78 and 5.82 cents based on 258,000,000 shares. That reported summary is retained separately from the original audited IPO EPS basis.

On 30 May 2025 each of the original 100,000 shares was subdivided into 2,250 shares, producing 225,000,000 shares without changing the S$100,000 share capital. On 4 July 2025 the Company issued 33,000,000 new shares at S$0.87, raising 28,710 thousand gross. Equity issuance expenses were 1,450 thousand; the separately expensed listing costs were 2,930 thousand. Closing ordinary shares were 258,000,000 and share capital 27,360 thousand.

FY2025 Group dividends of 6,499 thousand include a noncash offset of 1,188 thousand against shareholder loans; cash dividends were 5,311 thousand. FY2024 declared dividends of 12,500 less loan offset 10,837 plus the prior-year dividend payable 350 reconcile to cash dividends 2,013. The 774 thousand cash receipt from shareholder loan repayments is separately an investing cash flow.

FY2025 PPE acquisition of 3,140 thousand includes noncash right-of-use assets of 2,178; cash PPE purchase is 962. FY2024 acquisition of 2,324 includes right-of-use assets of 1,943; cash PPE purchase is 381. Right-of-use assets are within PPE and are not an extra asset to add to the balance sheet.

The lease liability reconciliation separates principal payments, interest paid, exchange movements, new leases, derecognition and interest expense. For FY2025, opening 3,542 less total cash outflow 1,477 less FX 114 plus other changes 2,042 equals closing 3,993, which is 2,808 noncurrent plus 1,185 current. FY2024 closing lease liabilities are 3,542, FY2023 2,750 and FY2022 2,844.

New right-of-use assets include reinstatement costs: FY2025 55 thousand and FY2024 7 thousand. Thus FY2025 ROU additions 2,178 differ from new lease liabilities 2,123, and FY2024 ROU additions 1,943 differ from new lease liabilities 1,936. Historical FY2022 ROU additions 2,706 include reinstatement costs 111 versus new lease liabilities 2,595.

Equity rows showing total comprehensive income and total owner transactions are subtotals, rather than additional movements to sum again. Currency translation reclassification on liquidation in FY2024 is retained alongside currency translation differences. No non-controlling interest is invented for wholly owned subsidiaries.

IPO Appendix A Note 21 says the April 2025 dividend of 2,500 thousand was fully settled through a loan offset of 1,188 and cash repayment 774; those two printed amounts sum to 1,962. The annual report separately shows the 774 shareholder loan repayment as an investing cash receipt and reconciles full-year dividends using 6,499 less 1,188 equals 5,311 cash. No missing payment or balancing item is invented. The IPO subsequent-event split wording refers to subdivision into 225,000,000 shares; the annual Note 10 explicitly gives the actual 1:2,250 split from 100,000 to 225,000,000 shares.

Printed dashes are retained as printed. Unlabelled original subtotals are explicitly marked as unlabelled in source. Source links identify the original document and physical page for each row.

FY2023 reported EBITDA in the annual financial highlights is 15,137 thousand, while original operating profit 13,233 plus depreciation 1,612 and amortisation 291 equals 15,136. The printed one-thousand discrepancy is preserved without inventing a rounding or other adjustment.

The complete reported four-year financial highlights include unadjusted EBITDA, three margins, EPS on 258 million shares and dividend per share. FY2025 headline adjusted PAT and adjusted EBITDA on the separate highlights page exclude approximately 2.9 million listing and 0.1 million Malaysia relocation expenses; they are not substituted for statutory profit or the unadjusted EBITDA summary. The summary FY2025 DPS 3.50 cents comprises interim 1.55 cents and final 1.95 cents proposed at the annual-report date; final dividend approval is established by the 24 April 2026 AGM results. Earlier DPS summary dashes are retained despite separate pre-IPO absolute dividend disclosures in the statutory notes.

Group changes in equity / 2022

7 metrics

Units appear below each metric. Scroll to compare years

Group changes in equity / 2022 from Annual Report 2025
Metric / unit 2022Group / Share capital / 12-month period 2022-01-01 to 2022-12-312022Group / Retained earnings / 12-month period 2022-01-01 to 2022-12-312022Group / Translation reserve / 12-month period 2022-01-01 to 2022-12-312022Group / Total equity / 12-month period 2022-01-01 to 2022-12-31 Source
Changes in equity / Group / 2022
At 1 January 2022Singapore dollars thousands 100586(3)683 PDF p. 222
Profit for the yearSingapore dollars thousands –7,185–7,185 PDF p. 222
– Currency translation differencesSingapore dollars thousands ––3434 PDF p. 222
Total comprehensive income for the yearSingapore dollars thousands –7,185347,219 PDF p. 222
Dividends declaredSingapore dollars thousands –(7,100)–(7,100) PDF p. 222
Total transactions with ownersSingapore dollars thousands –(7,100)–(7,100) PDF p. 222
At 31 December 2022Singapore dollars thousands 10067131802 PDF p. 222
Definitions & sources

Four available complete audited Group annual periods are FY2022–FY2025, each 1 January to 31 December. The FY2025 annual report is the first published annual report following the 4 July 2025 SGX listing. FY2022–FY2024 actual consolidated statements are in Appendix A of the official SGX final prospectus dated 27 June 2025. Appendix B unaudited pro forma FY2024 is not substituted for those actual statements. A full FY2021 audited annual statement source has not been established; the opening equity balance at 1 January 2022 is not a complete FY2021 statement set.

All monetary statement amounts are Singapore dollars thousands; basic and diluted earnings per share are Singapore cents. The latest annual report discloses financial position for Group and Company, and Group consolidated combined profit or loss and other comprehensive income, changes in equity and cash flows. Separate Company income, OCI, equity and cash-flow primary statements are not disclosed in the inspected annual report. The historical Appendix A statements are Group consolidated.

The FY2025 audit opinion is unmodified, KPMG LLP, partner Sarina Lee, dated 27 March 2026. Revenue recognition is a key audit matter; the annual auditor report discusses subscription revenue of 39,102 thousand, 69% of revenue. The historical FY2022–FY2024 Appendix A audit opinion is unmodified, KPMG LLP, Sarina Lee, dated 20 June 2025 except for Note 21 subsequent event, for which the date is 27 June 2025. Its report restricts use to inclusion in the listing prospectus.

The current annual report and historical IPO actual statements agree on FY2024 monetary values; original captions, nil rows and cash-flow row order can differ. The original IPO FY2024 income and EPS statement is retained because its EPS denominator differs from the annual comparative.

The FY2025 annual report Note 20 explicitly computes both FY2025 and FY2024 comparative basic EPS using 258,000 thousand shares, assuming that the share split and issuance of new shares had been effected for comparative purposes. EPS is 5.82 cents and 4.78 cents from profits of 15,020 and 12,339 thousand. This is the stated assumed share-capital basis; it is not labelled as an actual time-weighted share count.

The IPO Appendix A Note 19 uses the pre-invitation share capital of 225,000 thousand shares for FY2024, FY2023 and FY2022. Original EPS is respectively 5.48, 4.66 and 3.19 cents on profits of 12,339, 10,487 and 7,185 thousand. Basic and diluted EPS are equal because there are no potential dilutive ordinary shares. The annual-report financial highlights separately disclose FY2022–FY2025 EPS of 2.78, 4.06, 4.78 and 5.82 cents based on 258,000,000 shares. That reported summary is retained separately from the original audited IPO EPS basis.

On 30 May 2025 each of the original 100,000 shares was subdivided into 2,250 shares, producing 225,000,000 shares without changing the S$100,000 share capital. On 4 July 2025 the Company issued 33,000,000 new shares at S$0.87, raising 28,710 thousand gross. Equity issuance expenses were 1,450 thousand; the separately expensed listing costs were 2,930 thousand. Closing ordinary shares were 258,000,000 and share capital 27,360 thousand.

FY2025 Group dividends of 6,499 thousand include a noncash offset of 1,188 thousand against shareholder loans; cash dividends were 5,311 thousand. FY2024 declared dividends of 12,500 less loan offset 10,837 plus the prior-year dividend payable 350 reconcile to cash dividends 2,013. The 774 thousand cash receipt from shareholder loan repayments is separately an investing cash flow.

FY2025 PPE acquisition of 3,140 thousand includes noncash right-of-use assets of 2,178; cash PPE purchase is 962. FY2024 acquisition of 2,324 includes right-of-use assets of 1,943; cash PPE purchase is 381. Right-of-use assets are within PPE and are not an extra asset to add to the balance sheet.

The lease liability reconciliation separates principal payments, interest paid, exchange movements, new leases, derecognition and interest expense. For FY2025, opening 3,542 less total cash outflow 1,477 less FX 114 plus other changes 2,042 equals closing 3,993, which is 2,808 noncurrent plus 1,185 current. FY2024 closing lease liabilities are 3,542, FY2023 2,750 and FY2022 2,844.

New right-of-use assets include reinstatement costs: FY2025 55 thousand and FY2024 7 thousand. Thus FY2025 ROU additions 2,178 differ from new lease liabilities 2,123, and FY2024 ROU additions 1,943 differ from new lease liabilities 1,936. Historical FY2022 ROU additions 2,706 include reinstatement costs 111 versus new lease liabilities 2,595.

Equity rows showing total comprehensive income and total owner transactions are subtotals, rather than additional movements to sum again. Currency translation reclassification on liquidation in FY2024 is retained alongside currency translation differences. No non-controlling interest is invented for wholly owned subsidiaries.

IPO Appendix A Note 21 says the April 2025 dividend of 2,500 thousand was fully settled through a loan offset of 1,188 and cash repayment 774; those two printed amounts sum to 1,962. The annual report separately shows the 774 shareholder loan repayment as an investing cash receipt and reconciles full-year dividends using 6,499 less 1,188 equals 5,311 cash. No missing payment or balancing item is invented. The IPO subsequent-event split wording refers to subdivision into 225,000,000 shares; the annual Note 10 explicitly gives the actual 1:2,250 split from 100,000 to 225,000,000 shares.

Printed dashes are retained as printed. Unlabelled original subtotals are explicitly marked as unlabelled in source. Source links identify the original document and physical page for each row.

FY2023 reported EBITDA in the annual financial highlights is 15,137 thousand, while original operating profit 13,233 plus depreciation 1,612 and amortisation 291 equals 15,136. The printed one-thousand discrepancy is preserved without inventing a rounding or other adjustment.

The complete reported four-year financial highlights include unadjusted EBITDA, three margins, EPS on 258 million shares and dividend per share. FY2025 headline adjusted PAT and adjusted EBITDA on the separate highlights page exclude approximately 2.9 million listing and 0.1 million Malaysia relocation expenses; they are not substituted for statutory profit or the unadjusted EBITDA summary. The summary FY2025 DPS 3.50 cents comprises interim 1.55 cents and final 1.95 cents proposed at the annual-report date; final dividend approval is established by the 24 April 2026 AGM results. Earlier DPS summary dashes are retained despite separate pre-IPO absolute dividend disclosures in the statutory notes.

Group income and EPS / retained FY2024 original IPO statement

20 metrics

Units appear below each metric. Scroll to compare years

Group income and EPS / retained FY2024 original IPO statement from Annual Report 2025
Metric / unit 2024Group / original IPO actual / EPS on pre-invitation 225 million shares / 12-month period 2024-01-01 to 2024-12-31 Source
income
RevenueSingapore dollars thousands 43,713 PDF p. 221
Cost of salesSingapore dollars thousands (6,297) PDF p. 221
Gross profitSingapore dollars thousands 37,416 PDF p. 221
Other incomeSingapore dollars thousands 115 PDF p. 221
Selling and distribution expensesSingapore dollars thousands (9,492) PDF p. 221
Administrative expensesSingapore dollars thousands (8,920) PDF p. 221
Research and development expensesSingapore dollars thousands (3,693) PDF p. 221
Other expensesSingapore dollars thousands (515) PDF p. 221
Operating profitSingapore dollars thousands 14,911 PDF p. 221
Finance incomeSingapore dollars thousands 325 PDF p. 221
Finance costsSingapore dollars thousands (338) PDF p. 221
Net finance costsSingapore dollars thousands (13) PDF p. 221
Profit before taxSingapore dollars thousands 14,898 PDF p. 221
Tax expenseSingapore dollars thousands (2,559) PDF p. 221
Profit for the yearSingapore dollars thousands 12,339 PDF p. 221
Foreign operations:
– Currency translation differencesSingapore dollars thousands (147) PDF p. 221
– Currency translation differences reclassified to profit or loss on liquidation of subsidiariesSingapore dollars thousands (65) PDF p. 221
Total comprehensive income
Total comprehensive income for the year attributable to the Owners of the CompanySingapore dollars thousands 12,127 PDF p. 221
Earnings per share attributable to the ordinary equity holders of the Company during the financial year
Basic earnings per share (cents)Singapore cents per share 5.48 PDF p. 221
Diluted earnings per share (cents)Singapore cents per share 5.48 PDF p. 221
Definitions & sources

Four available complete audited Group annual periods are FY2022–FY2025, each 1 January to 31 December. The FY2025 annual report is the first published annual report following the 4 July 2025 SGX listing. FY2022–FY2024 actual consolidated statements are in Appendix A of the official SGX final prospectus dated 27 June 2025. Appendix B unaudited pro forma FY2024 is not substituted for those actual statements. A full FY2021 audited annual statement source has not been established; the opening equity balance at 1 January 2022 is not a complete FY2021 statement set.

All monetary statement amounts are Singapore dollars thousands; basic and diluted earnings per share are Singapore cents. The latest annual report discloses financial position for Group and Company, and Group consolidated combined profit or loss and other comprehensive income, changes in equity and cash flows. Separate Company income, OCI, equity and cash-flow primary statements are not disclosed in the inspected annual report. The historical Appendix A statements are Group consolidated.

The FY2025 audit opinion is unmodified, KPMG LLP, partner Sarina Lee, dated 27 March 2026. Revenue recognition is a key audit matter; the annual auditor report discusses subscription revenue of 39,102 thousand, 69% of revenue. The historical FY2022–FY2024 Appendix A audit opinion is unmodified, KPMG LLP, Sarina Lee, dated 20 June 2025 except for Note 21 subsequent event, for which the date is 27 June 2025. Its report restricts use to inclusion in the listing prospectus.

The current annual report and historical IPO actual statements agree on FY2024 monetary values; original captions, nil rows and cash-flow row order can differ. The original IPO FY2024 income and EPS statement is retained because its EPS denominator differs from the annual comparative.

The FY2025 annual report Note 20 explicitly computes both FY2025 and FY2024 comparative basic EPS using 258,000 thousand shares, assuming that the share split and issuance of new shares had been effected for comparative purposes. EPS is 5.82 cents and 4.78 cents from profits of 15,020 and 12,339 thousand. This is the stated assumed share-capital basis; it is not labelled as an actual time-weighted share count.

The IPO Appendix A Note 19 uses the pre-invitation share capital of 225,000 thousand shares for FY2024, FY2023 and FY2022. Original EPS is respectively 5.48, 4.66 and 3.19 cents on profits of 12,339, 10,487 and 7,185 thousand. Basic and diluted EPS are equal because there are no potential dilutive ordinary shares. The annual-report financial highlights separately disclose FY2022–FY2025 EPS of 2.78, 4.06, 4.78 and 5.82 cents based on 258,000,000 shares. That reported summary is retained separately from the original audited IPO EPS basis.

On 30 May 2025 each of the original 100,000 shares was subdivided into 2,250 shares, producing 225,000,000 shares without changing the S$100,000 share capital. On 4 July 2025 the Company issued 33,000,000 new shares at S$0.87, raising 28,710 thousand gross. Equity issuance expenses were 1,450 thousand; the separately expensed listing costs were 2,930 thousand. Closing ordinary shares were 258,000,000 and share capital 27,360 thousand.

FY2025 Group dividends of 6,499 thousand include a noncash offset of 1,188 thousand against shareholder loans; cash dividends were 5,311 thousand. FY2024 declared dividends of 12,500 less loan offset 10,837 plus the prior-year dividend payable 350 reconcile to cash dividends 2,013. The 774 thousand cash receipt from shareholder loan repayments is separately an investing cash flow.

FY2025 PPE acquisition of 3,140 thousand includes noncash right-of-use assets of 2,178; cash PPE purchase is 962. FY2024 acquisition of 2,324 includes right-of-use assets of 1,943; cash PPE purchase is 381. Right-of-use assets are within PPE and are not an extra asset to add to the balance sheet.

The lease liability reconciliation separates principal payments, interest paid, exchange movements, new leases, derecognition and interest expense. For FY2025, opening 3,542 less total cash outflow 1,477 less FX 114 plus other changes 2,042 equals closing 3,993, which is 2,808 noncurrent plus 1,185 current. FY2024 closing lease liabilities are 3,542, FY2023 2,750 and FY2022 2,844.

New right-of-use assets include reinstatement costs: FY2025 55 thousand and FY2024 7 thousand. Thus FY2025 ROU additions 2,178 differ from new lease liabilities 2,123, and FY2024 ROU additions 1,943 differ from new lease liabilities 1,936. Historical FY2022 ROU additions 2,706 include reinstatement costs 111 versus new lease liabilities 2,595.

Equity rows showing total comprehensive income and total owner transactions are subtotals, rather than additional movements to sum again. Currency translation reclassification on liquidation in FY2024 is retained alongside currency translation differences. No non-controlling interest is invented for wholly owned subsidiaries.

IPO Appendix A Note 21 says the April 2025 dividend of 2,500 thousand was fully settled through a loan offset of 1,188 and cash repayment 774; those two printed amounts sum to 1,962. The annual report separately shows the 774 shareholder loan repayment as an investing cash receipt and reconciles full-year dividends using 6,499 less 1,188 equals 5,311 cash. No missing payment or balancing item is invented. The IPO subsequent-event split wording refers to subdivision into 225,000,000 shares; the annual Note 10 explicitly gives the actual 1:2,250 split from 100,000 to 225,000,000 shares.

Printed dashes are retained as printed. Unlabelled original subtotals are explicitly marked as unlabelled in source. Source links identify the original document and physical page for each row.

FY2023 reported EBITDA in the annual financial highlights is 15,137 thousand, while original operating profit 13,233 plus depreciation 1,612 and amortisation 291 equals 15,136. The printed one-thousand discrepancy is preserved without inventing a rounding or other adjustment.

The complete reported four-year financial highlights include unadjusted EBITDA, three margins, EPS on 258 million shares and dividend per share. FY2025 headline adjusted PAT and adjusted EBITDA on the separate highlights page exclude approximately 2.9 million listing and 0.1 million Malaysia relocation expenses; they are not substituted for statutory profit or the unadjusted EBITDA summary. The summary FY2025 DPS 3.50 cents comprises interim 1.55 cents and final 1.95 cents proposed at the annual-report date; final dividend approval is established by the 24 April 2026 AGM results. Earlier DPS summary dashes are retained despite separate pre-IPO absolute dividend disclosures in the statutory notes.

Where the money comes from

Segment information

By business

Reconciliations of reportable segment revenue, profit or loss, assets and liabilities 17 lines
Reconciliations of reportable segment revenue, profit or loss, assets and liabilities
Item / unit 2025Group2024Group Source
Revenues
Total revenue for reportable segments$’000 57,01644,179 PDF p. 87
Revenue for other segments$’000 7,9066,386 PDF p. 87
Elimination of inter-segment revenue$’000 (8,436)(6,852) PDF p. 87
Consolidated revenue$’000 56,48643,713 PDF p. 87
Profit or loss before tax
Total profit before tax for reportable segments$’000 18,84714,955 PDF p. 87
Profit/(Loss) before tax for other segments$’000 215(391) PDF p. 87
Elimination of inter-segment profits$’000 –334 PDF p. 87
Consolidated profit before tax$’000 19,06214,898 PDF p. 87
Assets
Total assets^ for reportable segments$’000 77,84432,508 PDF p. 87
Total assets^ for other segments$’000 4,0385,562 PDF p. 87
Deferred tax assets$’000 2,0501,598 PDF p. 87
Consolidated total assets$’000 83,93239,668 PDF p. 87
Liabilities
Total liabilities* for reportable segments$’000 36,29529,123 PDF p. 87
Total liabilities* for other segments$’000 4,2924,194 PDF p. 87
Deferred tax liabilities$’000 12117 PDF p. 87
Current tax liabilities$’000 3,3382,352 PDF p. 87
Consolidated total liabilities$’000 44,04635,686 PDF p. 87
Notes

^ Exclude deferred tax assets

* Exclude deferred tax liabilities and current tax liabilities

The unlabelled subtotal 19,062 / 14,564 printed between 'Profit/(Loss) before tax for other segments' and 'Elimination of inter-segment profits' is not extracted as a row.

By geography

Information about reportable segments (geographical) 15 lines
Information about reportable segments (geographical)
Item / unit 2025Singapore2025Malaysia2025Others2025Total2024Singapore2024Malaysia2024Others2024Total Source
Information about reportable segments
External revenue$’000 42,65910,3083,51956,48632,8318,2402,64243,713 PDF p. 85PDF p. 86
Inter-segment revenue$’000 4,049–4,3878,4363,097113,7446,852 PDF p. 85PDF p. 86
Finance income$’000 46115–47631411–325 PDF p. 85PDF p. 86
Finance costs$’000 (174)(80)(98)(352)(181)(64)(93)(338) PDF p. 85PDF p. 86
Government grants income$’000 29––2934––34 PDF p. 85PDF p. 86
Depreciation of property, plant and equipment$’000 (1,059)(601)(390)(2,050)(973)(453)(331)(1,757) PDF p. 85PDF p. 86
Amortisation of intangible assets$’000 (146)–(22)(168)(334)–(12)(346) PDF p. 85PDF p. 86
Segment profit/(loss) before tax$’000 18,3413,333(2,612)19,06215,4712,423(2,996)14,898 PDF p. 85PDF p. 86
Other material items of income and expense and non-cash items
– Advertising expenses$’000 (2,724)(600)(536)(3,860)(2,323)(880)(518)(3,721) PDF p. 85PDF p. 86
– Hosting expenses$’000 (714)(321)(81)(1,116)(610)(336)(88)(1,034) PDF p. 85PDF p. 86
– Employee benefits expenses$’000 (13,884)(4,651)(4,169)(22,704)(11,103)(3,705)(3,784)(18,592) PDF p. 85PDF p. 86
Information about reportable segments
Reportable segment assets^$’000 64,84413,0004,03881,88223,5138,9955,56238,070 PDF p. 85PDF p. 86
Capital expenditure
– Property, plant and equipment#$’000 (807)(154)(1)(962)(47)(209)(125)(381) PDF p. 85PDF p. 86
– Intangible assets$’000 ––(24)(24)––(15)(15) PDF p. 85PDF p. 86
Information about reportable segments
Reportable segment liabilities*$’000 25,72410,5714,29240,58720,5328,5914,19433,317 PDF p. 85PDF p. 86
Notes

^ Exclude deferred tax assets; * Exclude deferred tax liabilities and current tax liabilities; # Exclude right-of-use assets (footnotes printed on page 86). Group has two reportable geographical segments (Singapore and Malaysia); Others = Hong Kong and India HRMS/accounting software sales.

^ Exclude deferred tax assets

* Exclude deferred tax liabilities and current tax liabilities

# Exclude right-of-use assets

Debt

Borrowings

Contractual maturities of lease liabilities (undiscounted)

Contractual maturities of lease liabilities (undiscounted)
Item / unit 2025Group2024Group2025Company2024Company Source
Group 31 December 2025: Carrying amount; Contractual cash flows; Within 1 year; Between 2 to 5 years
Lease liabilities (Group 2025)$'000 3,993(4,537)(1,388)(3,149) PDF p. 82
Group 31 December 2024: Carrying amount; Contractual cash flows; Within 1 year; Between 2 to 5 years
Lease liabilities (Group 2024)$'000 3,542(4,125)(1,313)(2,812) PDF p. 82
Company 31 December 2025: Carrying amount; Contractual cash flows; Within 1 year; Between 2 to 5 years
Lease liabilities (Company 2025)$'000 1,399(1,566)(655)(911) PDF p. 82
Company 31 December 2024: Carrying amount; Contractual cash flows; Within 1 year; Between 2 to 5 years
Lease liabilities (Company 2024)$'000 914(1,000)(755)(245) PDF p. 82
Notes

Amounts are gross and undiscounted, include contractual interest payments and exclude the impact of netting agreements. Each row's four values map to Carrying amount, Contractual cash flows, Within 1 year, Between 2 to 5 years. Column year/scope of table applies by row label.

Borrowing notes 1 tables

Lease liabilities, current and non-current

Lease liabilities, current and non-current
Item / unit 2025Group2024Group2025Company2024Company Source
Lease liabilities
Non-current$'000 2,8082,422829228 PDF p. 72
Current$'000 1,1851,120570686 PDF p. 72
Notes

The report discloses no bank borrowings (page 8 refers to zero borrowings); only lease liabilities are reported as debt. The unlabelled total row prints 3,993 3,542 1,399 914.

Payout

Dividends & distributions

Dividend policy

ItemValuePeriod / scopeSource
Dividend policy The Company does not have a fixed dividend policy. However, the Board intends to recommend and distribute at least 50% of its adjusted net profit after tax as dividends to shareholders for FY2025 and FY2026. Any dividend payouts will be communicated to shareholders via announcements on SGXNET when the Company releases its financial results. Company PDF p. 40

Dividends declared and proposed

ItemValuePeriod / scopeSource
Final dividend of 1.95 cent per ordinary share (2024: Nil) 1.95 cents per share Company, FY2025 final dividend proposed, exempt (one-tier) PDF p. 72
Second interim dividend of 1.55 cent (2024: $50) per ordinary share 1.55 cents per share Company, FY2025 second interim dividend declared, exempt (one-tier) PDF p. 71
First interim dividend of $25 (2024: $75) per ordinary share $25 Company, FY2025 first interim dividend declared, exempt (one-tier) PDF p. 71
Declared by the Company to owners of the Company 6,499 $'000 Company and Group, dividends declared FY2025 (2024: 12,500) PDF p. 71
TOTAL DIVIDEND 3.50 cents per ordinary share FY2025 total (interim 1.55 paid + final 1.95 proposed) PDF p. 9

Payout

ItemValuePeriod / scopeSource
Dividend and Outlook approximately 60% of net profit after tax and 50% of adjusted net profit after tax FY2025 PDF p. 9

Extracted from Annual Report 2025 and checked against the cited pages; see the original report for full context.

Auditor’s report

Audit & risk signals

Audit opinion

ItemValuePeriod / scopeSource
Audit firm KPMG LLP Group, FY2025 PDF p. 46
Engagement partner Sarina Lee Group, FY2025 PDF p. 46
Opinion In our opinion, the accompanying consolidated financial statements of the Group and the statement of financial position of the Company are properly drawn up Group and Company, as at 31 December 2025 PDF p. 44

Key audit matters

ItemValuePeriod / scopeSource
Revenue Recognition Revenue Recognition Group, FY2025 PDF p. 44
Revenue Recognition – description The calculation of subscription revenue and the related contract liabilities involve manual computations. Group, FY2025 PDF p. 44

Extracted from Annual Report 2025 and checked against the cited pages; see the original report for full context.

How to read these figures

Group and parent company or bank figures are labelled separately. Parentheses indicate negative amounts; a dash and NA retain the report’s notation.

Comparative figures follow Annual Report 2025, including retrospective adjustments. Adjusted and reported earnings may have different definitions; refer to each statement’s notes.

Four available complete audited Group annual periods are FY2022–FY2025, each 1 January to 31 December. The FY2025 annual report is the first published annual report following the 4 July 2025 SGX listing. FY2022–FY2024 actual consolidated statements are in Appendix A of the official SGX final prospectus dated 27 June 2025. Appendix B unaudited pro forma FY2024 is not substituted for those actual statements. A full FY2021 audited annual statement source has not been established; the opening equity balance at 1 January 2022 is not a complete FY2021 statement set.

All monetary statement amounts are Singapore dollars thousands; basic and diluted earnings per share are Singapore cents. The latest annual report discloses financial position for Group and Company, and Group consolidated combined profit or loss and other comprehensive income, changes in equity and cash flows. Separate Company income, OCI, equity and cash-flow primary statements are not disclosed in the inspected annual report. The historical Appendix A statements are Group consolidated.

The FY2025 audit opinion is unmodified, KPMG LLP, partner Sarina Lee, dated 27 March 2026. Revenue recognition is a key audit matter; the annual auditor report discusses subscription revenue of 39,102 thousand, 69% of revenue. The historical FY2022–FY2024 Appendix A audit opinion is unmodified, KPMG LLP, Sarina Lee, dated 20 June 2025 except for Note 21 subsequent event, for which the date is 27 June 2025. Its report restricts use to inclusion in the listing prospectus.

The current annual report and historical IPO actual statements agree on FY2024 monetary values; original captions, nil rows and cash-flow row order can differ. The original IPO FY2024 income and EPS statement is retained because its EPS denominator differs from the annual comparative.

The FY2025 annual report Note 20 explicitly computes both FY2025 and FY2024 comparative basic EPS using 258,000 thousand shares, assuming that the share split and issuance of new shares had been effected for comparative purposes. EPS is 5.82 cents and 4.78 cents from profits of 15,020 and 12,339 thousand. This is the stated assumed share-capital basis; it is not labelled as an actual time-weighted share count.

The IPO Appendix A Note 19 uses the pre-invitation share capital of 225,000 thousand shares for FY2024, FY2023 and FY2022. Original EPS is respectively 5.48, 4.66 and 3.19 cents on profits of 12,339, 10,487 and 7,185 thousand. Basic and diluted EPS are equal because there are no potential dilutive ordinary shares. The annual-report financial highlights separately disclose FY2022–FY2025 EPS of 2.78, 4.06, 4.78 and 5.82 cents based on 258,000,000 shares. That reported summary is retained separately from the original audited IPO EPS basis.

On 30 May 2025 each of the original 100,000 shares was subdivided into 2,250 shares, producing 225,000,000 shares without changing the S$100,000 share capital. On 4 July 2025 the Company issued 33,000,000 new shares at S$0.87, raising 28,710 thousand gross. Equity issuance expenses were 1,450 thousand; the separately expensed listing costs were 2,930 thousand. Closing ordinary shares were 258,000,000 and share capital 27,360 thousand.

FY2025 Group dividends of 6,499 thousand include a noncash offset of 1,188 thousand against shareholder loans; cash dividends were 5,311 thousand. FY2024 declared dividends of 12,500 less loan offset 10,837 plus the prior-year dividend payable 350 reconcile to cash dividends 2,013. The 774 thousand cash receipt from shareholder loan repayments is separately an investing cash flow.

FY2025 PPE acquisition of 3,140 thousand includes noncash right-of-use assets of 2,178; cash PPE purchase is 962. FY2024 acquisition of 2,324 includes right-of-use assets of 1,943; cash PPE purchase is 381. Right-of-use assets are within PPE and are not an extra asset to add to the balance sheet.

The lease liability reconciliation separates principal payments, interest paid, exchange movements, new leases, derecognition and interest expense. For FY2025, opening 3,542 less total cash outflow 1,477 less FX 114 plus other changes 2,042 equals closing 3,993, which is 2,808 noncurrent plus 1,185 current. FY2024 closing lease liabilities are 3,542, FY2023 2,750 and FY2022 2,844.

New right-of-use assets include reinstatement costs: FY2025 55 thousand and FY2024 7 thousand. Thus FY2025 ROU additions 2,178 differ from new lease liabilities 2,123, and FY2024 ROU additions 1,943 differ from new lease liabilities 1,936. Historical FY2022 ROU additions 2,706 include reinstatement costs 111 versus new lease liabilities 2,595.

Equity rows showing total comprehensive income and total owner transactions are subtotals, rather than additional movements to sum again. Currency translation reclassification on liquidation in FY2024 is retained alongside currency translation differences. No non-controlling interest is invented for wholly owned subsidiaries.

IPO Appendix A Note 21 says the April 2025 dividend of 2,500 thousand was fully settled through a loan offset of 1,188 and cash repayment 774; those two printed amounts sum to 1,962. The annual report separately shows the 774 shareholder loan repayment as an investing cash receipt and reconciles full-year dividends using 6,499 less 1,188 equals 5,311 cash. No missing payment or balancing item is invented. The IPO subsequent-event split wording refers to subdivision into 225,000,000 shares; the annual Note 10 explicitly gives the actual 1:2,250 split from 100,000 to 225,000,000 shares.

Printed dashes are retained as printed. Unlabelled original subtotals are explicitly marked as unlabelled in source. Source links identify the original document and physical page for each row.

FY2023 reported EBITDA in the annual financial highlights is 15,137 thousand, while original operating profit 13,233 plus depreciation 1,612 and amortisation 291 equals 15,136. The printed one-thousand discrepancy is preserved without inventing a rounding or other adjustment.

The complete reported four-year financial highlights include unadjusted EBITDA, three margins, EPS on 258 million shares and dividend per share. FY2025 headline adjusted PAT and adjusted EBITDA on the separate highlights page exclude approximately 2.9 million listing and 0.1 million Malaysia relocation expenses; they are not substituted for statutory profit or the unadjusted EBITDA summary. The summary FY2025 DPS 3.50 cents comprises interim 1.55 cents and final 1.95 cents proposed at the annual-report date; final dividend approval is established by the 24 April 2026 AGM results. Earlier DPS summary dashes are retained despite separate pre-IPO absolute dividend disclosures in the statutory notes.

These tables show the available extracted figures. The original annual report contains the full statements, notes and definitions.